{
  "ctx_json": {
    "main": "ATXN3",
    "interactors": [
      {
        "primary": "VCP",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 contains a VCP binding motif (VBM) and directly interacts with VCP/p97, an AAA+ ATPase involved in protein quality control, including ER-associated degradation (ERAD).",
        "functions": [
          {
            "function": "ER-Associated Degradation (ERAD)",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 directly binds to the AAA+ ATPase VCP/p97, a crucial enzyme for extracting misfolded proteins from the endoplasmic reticulum (ER) lumen to the cytosol for proteasomal degradation. ATXN3 and the VCP cofactor Ufd1 bind to VCP in a mutually exclusive manner.",
            "effect_description": "By binding to VCP, ATXN3 competes with Ufd1, which reduces VCP's association with ubiquitinated substrates. This inhibits the retrotranslocation of ERAD substrates from the ER, slowing their degradation. This effect is exacerbated by polyQ-expanded ATXN3, leading to the accumulation of misfolded proteins and ER stress.",
            "biological_consequence": [
              "ATXN3 binds to VCP/p97 → ATXN3 competes with Ufd1 for VCP binding → VCP's interaction with ubiquitinated substrates is reduced → Retrotranslocation of misfolded proteins from the ER is inhibited → Accumulation of ERAD substrates (e.g., CD3delta) → ER stress"
            ],
            "specific_effects": [
              "Inhibits VCP-dependent extraction of proteins from the ER.",
              "Decreases the degradation rate of ERAD substrates like CD3delta.",
              "Competes with VCP cofactor Ufd1 for VCP binding, thereby decreasing the interaction of VCP with ubiquitylated proteins."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Binds VCP/p97 and Regulates Retrotranslocation of ERAD Substrates",
                "journal": "PLoS ONE",
                "year": 2006,
                "relevant_quote": "These data suggest that a normal function of AT3 is to regulate flow through the ERAD pathway by modulating VCP-dependent extraction of proteins from the ER.",
                "pmid": "16822850"
              }
            ],
            "pathway": {
              "name": "ER-Associated Degradation (ERAD)",
              "canonical_name": "ER-Associated Degradation",
              "ontology_id": "GO:0036503",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "16822850"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "main_to_primary",
            "function_effect": "inhibition"
          },
          {
            "function": "Autophagy Initiation",
            "arrow": "activates",
            "cellular_process": "The ATXN3-VCP complex plays a key role in the initiation of autophagy by regulating the stability of BECN1 (Beclin-1), a core component of the class III phosphatidylinositol 3-kinase (PtdIns3K) complex.",
            "effect_description": "VCP stimulates the deubiquitinase activity of ATXN3, which in turn deubiquitinates and stabilizes BECN1. This prevents BECN1 from undergoing proteasomal degradation, leading to the stable assembly of the PtdIns3K complex, increased PtdIns3P production, and the formation of autophagosomes.",
            "biological_consequence": [
              "ATXN3 and VCP form a complex with BECN1 → VCP stimulates ATXN3's deubiquitinase activity → ATXN3 deubiquitinates and stabilizes BECN1 → PtdIns3K complex assembly is promoted → PtdIns3P production increases → Autophagosome formation is initiated"
            ],
            "specific_effects": [
              "Inhibiting VCP activity accelerates BECN1 degradation.",
              "ATXN3-mediated deubiquitination of BECN1 is critical for its stability.",
              "The ATXN3-VCP interaction promotes the assembly and kinase activity of the PtdIns3K complex."
            ],
            "evidence": [
              {
                "paper_title": "VCP/p97 modulates PtdIns3P production and autophagy initiation",
                "journal": "Autophagy",
                "year": 2021,
                "relevant_quote": "VCP stimulates the deubiquitinase activity of ATXN3 (ataxin 3) to stabilize BECN1 protein levels and also interacts with and promotes the assembly and kinase activity of the PtdIns3K complex.",
                "pmid": "33719912"
              },
              {
                "paper_title": "VCP/p97 UFMylation stabilizes BECN1 and facilitates the initiation of autophagy",
                "journal": "Autophagy",
                "year": 2024,
                "relevant_quote": "Mechanistically, VCP/p97 UFMylation stabilizes BECN1 through ATXN3 (ataxin 3)-mediated deubiquitination.",
                "pmid": "38762759"
              }
            ],
            "pathway": {
              "name": "Autophagy",
              "canonical_name": "Autophagy",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "33719912",
              "38762759"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "primary_to_main",
            "function_effect": "activation"
          },
          {
            "function": "Lysosome Regeneration",
            "arrow": "activates",
            "cellular_process": "Following lysosomal membrane damage, ATXN3 and its partner VCP/p97 are recruited to a subset of damaged lysosomes to facilitate their repair and regeneration.",
            "effect_description": "The ATXN3-VCP complex specifically targets and processes K48-K63-branched ubiquitin chains on lysosomal membrane proteins, such as LAMP2. This action facilitates the degradation of these ubiquitinated proteins via microautophagy, a crucial step for regenerating the lysosomal membrane and restoring the degradative capacity of the lysosomal system.",
            "biological_consequence": [
              "Lysosomal membrane damage → Recruitment of ATXN3/VCP complex to damaged lysosomes → ATXN3 targets and processes K48-K63-branched ubiquitin chains on LAMP2 → Degradation of ubiquitinated LAMP2 via microautophagy → Lysosomal membrane is regenerated → Lysophagic flux and functionality are restored"
            ],
            "specific_effects": [
              "Required for restoring lysophagic flux after lysosomal damage.",
              "Specifically targets and turns over K48-K63-branched ubiquitin conjugates.",
              "Promotes the degradation of a fraction of LAMP2 to regenerate the lysosomal membrane."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains",
                "journal": "The EMBO Journal",
                "year": 2025,
                "relevant_quote": "There, ATXN3, along with its partner VCP/p97, targets and turns over K48-K63-branched ubiquitin conjugates. ATXN3 thus facilitates degradation of a fraction of LAMP2 via microautophagy to regenerate the lysosomal membrane and to thereby reestablish degradative capacity needed also for completion of lysophagy.",
                "pmid": "40730717"
              }
            ],
            "pathway": {
              "name": "Autophagy",
              "canonical_name": "Autophagy",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "40730717"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "bidirectional",
            "function_effect": "activation"
          },
          {
            "function": "Mitophagy",
            "arrow": "activates",
            "cellular_process": "The ATXN3-VCP complex is involved in the quality control of mitochondria, specifically in the clearance of damaged mitochondria through Parkin-mediated mitophagy.",
            "effect_description": "Following mitochondrial depolarization, the E3 ligase Parkin ubiquitinates outer mitochondrial membrane (OMM) proteins, such as VDAC1, flagging the damaged organelle for degradation. ATXN3 acts as a deubiquitinase for VDAC1, regulating its ubiquitination status. This editing of ubiquitin chains is a critical regulatory step for the efficient recognition and clearance of damaged mitochondria by the autophagy machinery.",
            "biological_consequence": [
              "Mitochondrial damage → PINK1 recruits Parkin to the OMM → Parkin ubiquitinates OMM proteins like VDAC1 → ATXN3 is recruited and deubiquitinates VDAC1 → Ubiquitin chain editing regulates recognition by autophagy receptors → Damaged mitochondrion is cleared by mitophagy"
            ],
            "specific_effects": [
              "Directly deubiquitinates the outer mitochondrial membrane protein VDAC1.",
              "Regulates Parkin-VDAC1-mediated mitophagy.",
              "Pathogenic ATXN3 alters VDAC1 deubiquitination, hindering mitophagy."
            ],
            "evidence": [
              {
                "paper_title": "Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination",
                "journal": "International Journal of Molecular Sciences",
                "year": 2022,
                "relevant_quote": "Therefore, our data point to VDAC1 as a new substrate of the deubiquitinase ataxin-3 and suggest that ataxin-3, a protein known to localize to mitochondria, is a crucial component of the canonical parkin-VDAC1-mediated mitophagy.",
                "pmid": "35682609"
              }
            ],
            "pathway": {
              "name": "Mitophagy",
              "canonical_name": "Mitophagy",
              "ontology_id": "GO:0000423",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "35682609"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "bidirectional",
            "function_effect": "activation"
          }
        ],
        "arrow": "regulates",
        "direction": "bidirectional",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates",
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 directly binds to the AAA+ ATPase VCP/p97, a crucial enzyme for extracting misfolded proteins ; The ATXN3-VCP complex plays a key role in the initiation of autophagy by regulating the stability of; Following lysosomal membrane damage, ATXN3 and its partner VCP/p97 are recruited to a subset of dama...",
        "effect": "By binding to VCP, ATXN3 competes with Ufd1, which reduces VCP's association with ubiquitinated substrates. This inhibits the retrotranslocation of ERAD substrates from the ER, slowing their degradation. This effect is exacerbated by polyQ-expanded ATXN3, leading to the accumulation of misfolded proteins and ER stress.; VCP stimulates the deubiquitinase activity of ATXN3, which in turn deubiquitinates and stabilizes BECN1. This prevents BECN1 from undergoing proteasomal degradation, leading to the stable assembly of the PtdIns3K complex, increased PtdIns3P production, and the formation of autophagosomes.; ...",
        "summary": "ATXN3 regulates VCP to control multiple cellular processes including er-associated degradation (erad), autophagy initiation, and lysosome regeneration, ultimately affecting er stress.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 Binds VCP/p97 and Regulates Retrotranslocation of ERAD Substrates",
            "journal": "PLoS ONE",
            "year": 2006,
            "relevant_quote": "These data suggest that a normal function of AT3 is to regulate flow through the ERAD pathway by modulating VCP-dependent extraction of proteins from the ER."
          },
          {
            "paper_title": "VCP/p97 modulates PtdIns3P production and autophagy initiation",
            "journal": "Autophagy",
            "year": 2021,
            "relevant_quote": "VCP stimulates the deubiquitinase activity of ATXN3 (ataxin 3) to stabilize BECN1 protein levels and also interacts with and promotes the assembly and kinase activity of the PtdIns3K complex."
          },
          {
            "paper_title": "VCP/p97 UFMylation stabilizes BECN1 and facilitates the initiation of autophagy",
            "journal": "Autophagy",
            "year": 2024,
            "relevant_quote": "Mechanistically, VCP/p97 UFMylation stabilizes BECN1 through ATXN3 (ataxin 3)-mediated deubiquitination."
          },
          {
            "paper_title": "ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains",
            "journal": "The EMBO Journal",
            "year": 2025,
            "relevant_quote": "There, ATXN3, along with its partner VCP/p97, targets and turns over K48-K63-branched ubiquitin conjugates. ATXN3 thus facilitates degradation of a fraction of LAMP2 via microautophagy to regenerate the lysosomal membrane and to thereby reestablish degradative capacity needed also for completion of lysophagy."
          },
          {
            "paper_title": "Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination",
            "journal": "International Journal of Molecular Sciences",
            "year": 2022,
            "relevant_quote": "Therefore, our data point to VDAC1 as a new substrate of the deubiquitinase ataxin-3 and suggest that ataxin-3, a protein known to localize to mitochondria, is a crucial component of the canonical parkin-VDAC1-mediated mitophagy."
          }
        ],
        "pathways": [
          {
            "name": "Mitophagy",
            "canonical_name": "Mitophagy",
            "ontology_id": "GO:0000423",
            "ontology_source": "GO",
            "confidence": 0.8
          },
          {
            "name": "Autophagy",
            "canonical_name": "Autophagy",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          },
          {
            "name": "ER-Associated Degradation (ERAD)",
            "canonical_name": "ER-Associated Degradation",
            "ontology_id": "GO:0036503",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 5
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--regulates--> VCP:"
      },
      {
        "primary": "RAD23A",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with RAD23A, a protein involved in DNA repair and delivery of ubiquitinated substrates to the proteasome.",
        "functions": [
          {
            "function": "ATXN3 Proteasomal Degradation",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 protein levels are regulated by ubiquitination-independent proteasomal degradation. The proteasome-associated shuttle protein RAD23A directly interacts with ATXN3.",
            "effect_description": "RAD23A binds to the ubiquitin-binding site 2 (UbS2) on the N-terminus of ATXN3. This interaction shields ATXN3 from the proteasome, preventing its degradation and thereby increasing its protein stability and steady-state levels.",
            "biological_consequence": [
              "ATXN3 binds to RAD23A via its UbS2 domain → ATXN3 is shielded from the proteasome → Ubiquitination-independent degradation of ATXN3 is prevented → ATXN3 protein turnover is reduced → Cellular levels of ATXN3 are stabilized"
            ],
            "specific_effects": [
              "Interaction is mediated by the UbS2 domain of ATXN3.",
              "Disrupting the ATXN3-RAD23A interaction enhances ATXN3's proteasomal turnover.",
              "Knockdown of RAD23A leads to lower cellular levels of ATXN3 protein."
            ],
            "evidence": [
              {
                "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
                "journal": "Nature Communications",
                "year": 2014,
                "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein.",
                "pmid": "25144244"
              },
              {
                "paper_title": "Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3",
                "journal": "Human Molecular Genetics",
                "year": 2017,
                "relevant_quote": "According to our earlier published work, proteasomal degradation of ataxin-3 is regulated by the direct interaction between UbS2 and Rad23. When Rad23 is bound to UbS2, ataxin-3 is protected from degradation.",
                "pmid": "28158474"
              }
            ],
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "25144244",
              "28158474"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "primary_to_main",
            "function_effect": "inhibition"
          }
        ],
        "arrow": "binds",
        "direction": "primary_to_main",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 protein levels are regulated by ubiquitination-independent proteasomal degradation. The proteasome-associated shuttle protein RAD23A directly interacts with ATXN3.",
        "effect": "RAD23A binds to the ubiquitin-binding site 2 (UbS2) on the N-terminus of ATXN3. This interaction shields ATXN3 from the proteasome, preventing its degradation and thereby increasing its protein stability and steady-state levels.",
        "summary": "ATXN3 inhibits RAD23A to modulate atxn3 proteasomal degradation, ultimately affecting cellular levels of atxn3 are stabilized.",
        "evidence": [
          {
            "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
            "journal": "Nature Communications",
            "year": 2014,
            "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein."
          },
          {
            "paper_title": "Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3",
            "journal": "Human Molecular Genetics",
            "year": 2017,
            "relevant_quote": "According to our earlier published work, proteasomal degradation of ataxin-3 is regulated by the direct interaction between UbS2 and Rad23. When Rad23 is bound to UbS2, ataxin-3 is protected from degradation."
          }
        ],
        "pathways": [
          {
            "name": "Ubiquitin-Proteasome System",
            "canonical_name": "Proteasomal Degradation",
            "ontology_id": "GO:0010498",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--binds-- RAD23A:"
      },
      {
        "primary": "RAD23B",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with RAD23B, a homolog of RAD23A, which is also involved in DNA repair and proteasomal degradation pathways.",
        "functions": [
          {
            "function": "ATXN3 Proteasomal Degradation",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 protein stability is controlled via a ubiquitination-independent proteasomal pathway. RAD23B, a homolog of RAD23A, is a proteasome shuttle protein that directly interacts with ATXN3.",
            "effect_description": "Through its binding to the ubiquitin-binding site 2 (UbS2) of ATXN3, RAD23B protects ATXN3 from proteasomal degradation. This interaction effectively stabilizes the ATXN3 protein, leading to an increase in its cellular concentration.",
            "biological_consequence": [
              "ATXN3 binds to RAD23B via its UbS2 domain → ATXN3 is shielded from the proteasome → Ubiquitination-independent degradation of ATXN3 is prevented → ATXN3 protein turnover is reduced → Cellular levels of ATXN3 are stabilized"
            ],
            "specific_effects": [
              "Interaction is mediated by the UbS2 domain of ATXN3.",
              "Functionally redundant with RAD23A in regulating ATXN3 stability.",
              "Knockdown of Rad23 (both A and B) results in lower levels of ATXN3 protein."
            ],
            "evidence": [
              {
                "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
                "journal": "Nature Communications",
                "year": 2014,
                "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein.",
                "pmid": "25144244"
              }
            ],
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "25144244"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "primary_to_main",
            "function_effect": "inhibition"
          }
        ],
        "arrow": "binds",
        "direction": "primary_to_main",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 protein stability is controlled via a ubiquitination-independent proteasomal pathway. RAD23B, a homolog of RAD23A, is a proteasome shuttle protein that directly interacts with ATXN3.",
        "effect": "Through its binding to the ubiquitin-binding site 2 (UbS2) of ATXN3, RAD23B protects ATXN3 from proteasomal degradation. This interaction effectively stabilizes the ATXN3 protein, leading to an increase in its cellular concentration.",
        "summary": "ATXN3 inhibits RAD23B to modulate atxn3 proteasomal degradation, ultimately affecting cellular levels of atxn3 are stabilized.",
        "evidence": [
          {
            "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
            "journal": "Nature Communications",
            "year": 2014,
            "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein."
          }
        ],
        "pathways": [
          {
            "name": "Ubiquitin-Proteasome System",
            "canonical_name": "Proteasomal Degradation",
            "ontology_id": "GO:0010498",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--binds-- RAD23B:"
      },
      {
        "primary": "HDAC3",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 has been shown to directly interact with the transcriptional regulator Histone Deacetylase 3 (HDAC3).",
        "functions": [
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "Normal ATXN3 directly binds to the nuclear receptor corepressor (NCoR)/HDAC3 complex. ATXN3 facilitates the recruitment of this complex to specific gene promoters, such as the MMP-2 promoter, leading to the deacetylation of local histones.",
            "effect_description": "By recruiting the HDAC3-containing repressor complex to chromatin, ATXN3 promotes a condensed chromatin state, which silences gene expression. This function is impaired in polyQ-expanded ATXN3, which fails to efficiently recruit HDAC3 and repress transcription.",
            "biological_consequence": [
              "ATXN3 binds HDAC3 and NCoR → ATXN3-HDAC3-NCoR complex is recruited to gene promoters (e.g., MMP-2) → HDAC3 deacetylates histone tails → Chromatin becomes condensed → Transcription of target genes is repressed."
            ],
            "specific_effects": [
              "Normal ATXN3 is required for the efficient recruitment of HDAC3 to chromatin.",
              "The ATXN3-HDAC3 interaction controls the subcellular localization of HDAC3, promoting its nuclear retention.",
              "PolyQ-expanded ATXN3 still interacts with HDAC3 but loses the ability to form effective deacetylating repressor complexes on target chromatin regions.",
              "Normal ATXN3-containing complexes exhibit increased histone deacetylase activity, whereas complexes with expanded ATXN3 show reduced activity."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "journal": "The Journal of Neuroscience",
                "year": 2006,
                "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter.",
                "pmid": "17079677"
              },
              {
                "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
                "journal": "Nucleic Acids Research",
                "year": 2023,
                "relevant_quote": "The absence of ATXN3 decreases the recruitment of endogenous HDAC3 to the chromatin, as well as the HDAC3 nuclear/cytoplasm ratio after HDAC3 overexpression, suggesting that ATXN3 controls the subcellular localization of HDAC3.",
                "pmid": "36971114"
              }
            ],
            "pathway": {
              "name": "Transcriptional Regulation",
              "canonical_name": "Transcription",
              "ontology_id": "GO:0006351",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "17079677",
              "36971114"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          },
          {
            "function": "Protein Stabilization",
            "arrow": "activates",
            "cellular_process": "In the context of the innate immune response, ATXN3 acts as a deubiquitinase for HDAC3. It removes ubiquitin chains from HDAC3, thereby protecting it from proteasomal degradation.",
            "effect_description": "By deubiquitinating and stabilizing HDAC3, ATXN3 increases the overall protein levels of HDAC3. This stabilization enhances the Type I interferon (IFN-I)-mediated antiviral signaling pathway.",
            "biological_consequence": [
              "Viral infection increases ATXN3-HDAC3 interaction → ATXN3 deubiquitinates HDAC3 → HDAC3 is stabilized and protein levels increase → IFN-I-induced signaling is enhanced → Antiviral response is promoted."
            ],
            "specific_effects": [
              "ATXN3 physically interacts with and deubiquitinates HDAC3, enhancing its protein stability.",
              "This interaction is increased during viral infection.",
              "The ATXN3/HDAC3 axis positively regulates the Type I IFN antiviral response."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3",
                "journal": "The Journal of Immunology",
                "year": 2018,
                "relevant_quote": "Furthermore, ATXN3 physically interacts with histone deacetylase 3 (HDAC3) and upregulates the level of HDAC3 protein. Moreover, ATXN3 deubiquitinates HDAC3, thereby enhancing HDAC3 protein stability.",
                "pmid": "29802126"
              }
            ],
            "pathway": {
              "name": "Protein Stability Regulation",
              "canonical_name": "Protein Stability Regulation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "29802126"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "regulates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "Normal ATXN3 directly binds to the nuclear receptor corepressor (NCoR)/HDAC3 complex. ATXN3 facilitates the recruitment of this complex to specific gene promoters, such as the MMP-2 promoter, leading to the deacetylation of local histones. In the context of the innate immune response, ATXN3 acts as a deubiquitinase for HDAC3. It removes ubiquitin chains from HDAC3, thereby protecting it from proteasomal degradation.",
        "effect": "By recruiting the HDAC3-containing repressor complex to chromatin, ATXN3 promotes a condensed chromatin state, which silences gene expression. This function is impaired in polyQ-expanded ATXN3, which fails to efficiently recruit HDAC3 and repress transcription.; By deubiquitinating and stabilizing HDAC3, ATXN3 increases the overall protein levels of HDAC3. This stabilization enhances the Type I interferon (IFN-I)-mediated antiviral signaling pathway.",
        "summary": "ATXN3 regulates HDAC3 to regulate transcriptional repression and protein stabilization, ultimately affecting transcription of target genes is repressed.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
            "journal": "The Journal of Neuroscience",
            "year": 2006,
            "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
          },
          {
            "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
            "journal": "Nucleic Acids Research",
            "year": 2023,
            "relevant_quote": "The absence of ATXN3 decreases the recruitment of endogenous HDAC3 to the chromatin, as well as the HDAC3 nuclear/cytoplasm ratio after HDAC3 overexpression, suggesting that ATXN3 controls the subcellular localization of HDAC3."
          },
          {
            "paper_title": "ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3",
            "journal": "The Journal of Immunology",
            "year": 2018,
            "relevant_quote": "Furthermore, ATXN3 physically interacts with histone deacetylase 3 (HDAC3) and upregulates the level of HDAC3 protein. Moreover, ATXN3 deubiquitinates HDAC3, thereby enhancing HDAC3 protein stability."
          }
        ],
        "pathways": [
          {
            "name": "Transcriptional Regulation",
            "canonical_name": "Transcription",
            "ontology_id": "GO:0006351",
            "ontology_source": "GO",
            "confidence": 0.8
          },
          {
            "name": "Protein Stability Regulation",
            "canonical_name": "Protein Stability Regulation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --regulates--> HDAC3:"
      },
      {
        "primary": "HDAC6",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "Surface plasmon resonance (SPR) analysis provided the first evidence of direct binding of ATXN3 to HDAC6.",
        "functions": [
          {
            "function": "Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3's deubiquitinase activity is critical for preparing misfolded protein aggregates for clearance. It cleaves polyubiquitin chains on aggregated proteins, which exposes unanchored ubiquitin C-termini.",
            "effect_description": "The exposed ubiquitin C-termini, generated by ATXN3, act as a specific binding signal for the zinc finger ubiquitin-binding domain (ZnF-UBP) of HDAC6. HDAC6 then serves as an adaptor protein, linking the aggregate cargo to the dynein motor complex for retrograde transport along microtubules to the perinuclear aggresome.",
            "biological_consequence": [
              "Misfolded, polyubiquitinated proteins form aggregates → ATXN3 trims polyubiquitin chains on aggregates → Unanchored ubiquitin C-terminal diglycine motifs are exposed → HDAC6's ZnF-UBP domain specifically binds these motifs → HDAC6 recruits the dynein motor complex → Aggregate cargo is transported along microtubules to the aggresome."
            ],
            "specific_effects": [
              "ATXN3 associates with HDAC6 and dynein.",
              "ATXN3's deubiquitinase activity generates the specific binding signal (unanchored ubiquitin C-termini) required for HDAC6 recognition of aggregates.",
              "Knockdown of ATXN3 severely reduces the formation of aggresomes.",
              "This function requires both the catalytic activity and the ubiquitin-interacting motifs (UIMs) of ATXN3."
            ],
            "evidence": [
              {
                "paper_title": "Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini",
                "journal": "The Journal of Biological Chemistry",
                "year": 2012,
                "relevant_quote": "The unanchored ubiquitin C termini in the aggregates are generated in situ by aggregate-associated deubiquitinase ataxin-3. These results provide structural and mechanistic bases for the role of HDAC6 in aggresome formation... where the exposure of ubiquitin C termini within protein aggregates enables HDAC6 recognition and transport to the aggresome.",
                "pmid": "22069321"
              },
              {
                "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
                "journal": "Proceedings of the National Academy of Sciences of the United States of America",
                "year": 2005,
                "relevant_quote": "Cellular studies show that endogenous AT3 colocalizes with aggresomes and preaggresome particles... and associates with histone deacetylase 6 and dynein, proteins required for aggresome formation and transport of misfolded protein. Small interfering RNA knockdown of AT3 greatly reduces aggresomes... demonstrating a critical role of AT3 in this process.",
                "pmid": "15767577"
              }
            ],
            "pathway": {
              "name": "Aggresome Formation",
              "canonical_name": "Aggresome Formation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "22069321",
              "15767577"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "activates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "activates",
            "direct_arrow": "activates",
            "net_effect": "activation",
            "direct_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates",
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The claim of ATXN3 inhibiting HDAC6 in a transcriptional context is not well-supported by primary literature. The major, well-defined interaction relates to aggresome formation, where ATXN3's activity is upstream and essential for HDAC6 function, thus representing an activating role.",
        "mechanism": "ATXN3's deubiquitinase activity is critical for preparing misfolded protein aggregates for clearance. It cleaves polyubiquitin chains on aggregated proteins, which exposes unanchored ubiquitin C-termini.",
        "effect": "The exposed ubiquitin C-termini, generated by ATXN3, act as a specific binding signal for the zinc finger ubiquitin-binding domain (ZnF-UBP) of HDAC6. HDAC6 then serves as an adaptor protein, linking the aggregate cargo to the dynein motor complex for retrograde transport along microtubules to the perinuclear aggresome.",
        "summary": "ATXN3 activates HDAC6 to modulate aggresome formation, ultimately affecting aggregate cargo is transported along microtubules to the aggresome.",
        "evidence": [
          {
            "paper_title": "Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini",
            "journal": "The Journal of Biological Chemistry",
            "year": 2012,
            "relevant_quote": "The unanchored ubiquitin C termini in the aggregates are generated in situ by aggregate-associated deubiquitinase ataxin-3. These results provide structural and mechanistic bases for the role of HDAC6 in aggresome formation... where the exposure of ubiquitin C termini within protein aggregates enables HDAC6 recognition and transport to the aggresome."
          },
          {
            "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
            "journal": "Proceedings of the National Academy of Sciences of the United States of America",
            "year": 2005,
            "relevant_quote": "Cellular studies show that endogenous AT3 colocalizes with aggresomes and preaggresome particles... and associates with histone deacetylase 6 and dynein, proteins required for aggresome formation and transport of misfolded protein. Small interfering RNA knockdown of AT3 greatly reduces aggresomes... demonstrating a critical role of AT3 in this process."
          }
        ],
        "pathways": [
          {
            "name": "Aggresome Formation",
            "canonical_name": "Aggresome Formation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "activation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --activates--> HDAC6:"
      },
      {
        "primary": "CBP",
        "interaction_type": "complex",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the transcriptional coactivator CREB-binding protein (CBP), which has histone acetyltransferase (HAT) activity.",
        "functions": [
          {
            "function": "Transcriptional Co-repressor Activity",
            "arrow": "activates",
            "cellular_process": "ATXN3 can function as a transcriptional co-repressor by directly interacting with histone acetyltransferases (HATs), including CREB-binding protein (CBP) and p300.",
            "effect_description": "ATXN3 binds to CBP and inhibits its transcriptional coactivator function. One proposed mechanism is that the N-terminal domain of ATXN3 binds to histones, blocking the access of coactivators like CBP to their acetylation sites, thereby repressing transcription.",
            "biological_consequence": [
              "ATXN3 binds to histones via its N-terminal domain → Access of CBP to histone tails is sterically hindered → Histone acetylation by CBP is inhibited → Chromatin remains in a condensed state → Transcription of target genes is repressed."
            ],
            "specific_effects": [
              "ATXN3 interacts with CBP, p300, and PCAF and inhibits their coactivator-dependent transcription.",
              "The C-terminal domain of ATXN3 is required for binding to coactivators.",
              "The N-terminal domain of ATXN3 inhibits histone acetylation by p300 in vitro."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities",
                "journal": "The Journal of Biological Chemistry",
                "year": 2002,
                "relevant_quote": "In the present study we use cell transfections, in vitro binding, co-immunoprecipitations, and reporter assays to show that the polyglutamine disease protein, ataxin-3, interacts with the major histone acetyltransferases cAMP-response-element binding protein (CREB)-binding protein, p300, and p300/CREB-binding protein-associated factor and inhibits transcription by these coactivators.",
                "pmid": "12297501"
              }
            ],
            "pathway": {
              "name": "Transcriptional Regulation",
              "canonical_name": "Transcription",
              "ontology_id": "GO:0006351",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "12297501"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          },
          {
            "function": "CBP Stability (Indirect)",
            "arrow": "activates",
            "cellular_process": "In a transcription-coupled DNA repair complex involving Huntingtin (HTT) and POLR2A, ATXN3's deubiquitinase activity is required to protect CBP from ubiquitination and subsequent degradation.",
            "effect_description": "Within this specific complex, a decrease in ATXN3 activity leads to the ubiquitination and degradation of CBP. This, in turn, negatively impacts both transcription and DNA repair processes. Therefore, ATXN3 activity indirectly promotes CBP stability and function.",
            "biological_consequence": [
              "ATXN3 is part of a DNA repair complex with HTT, POLR2A, and CBP → Impaired complex function (e.g., by mutant HTT) reduces ATXN3 activity → CBP becomes ubiquitinated → CBP is targeted for proteasomal degradation → Transcription and DNA repair are impaired."
            ],
            "specific_effects": [
              "ATXN3 is a component of a transcription-coupled DNA repair complex that includes CBP.",
              "A decrease in Ataxin-3 activity within this context facilitates CBP ubiquitination and degradation."
            ],
            "evidence": [
              {
                "paper_title": "Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription",
                "journal": "eLife",
                "year": 2019,
                "relevant_quote": "A concomitant decrease in Ataxin-3 activity facilitates CBP ubiquitination and degradation, adversely impacting transcription and DNA repair.",
                "pmid": "30994454"
              }
            ],
            "pathway": {
              "name": "Protein Stability Regulation",
              "canonical_name": "Protein Stability Regulation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "30994454"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "regulates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input claim that ATXN3 directly inhibits CBP's HAT activity is supported by early literature. However, a more complex, indirect mechanism has also been described where ATXN3 activity is required to prevent the degradation of CBP, particularly in the context of Huntington's disease models.",
        "mechanism": "ATXN3 can function as a transcriptional co-repressor by directly interacting with histone acetyltransferases (HATs), including CREB-binding protein (CBP) and p300. In a transcription-coupled DNA repair complex involving Huntingtin (HTT) and POLR2A, ATXN3's deubiquitinase activity is required to protect CBP from ubiquitination and subsequent degradation.",
        "effect": "ATXN3 binds to CBP and inhibits its transcriptional coactivator function. One proposed mechanism is that the N-terminal domain of ATXN3 binds to histones, blocking the access of coactivators like CBP to their acetylation sites, thereby repressing transcription.; Within this specific complex, a decrease in ATXN3 activity leads to the ubiquitination and degradation of CBP. This, in turn, negatively impacts both transcription and DNA repair processes. Therefore, ATXN3 activity indirectly promotes CBP stability and function.",
        "summary": "ATXN3 regulates CBP to regulate transcriptional co-repressor activity and regulation of cbp stability (indirect), ultimately affecting transcription of target genes is repressed.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities",
            "journal": "The Journal of Biological Chemistry",
            "year": 2002,
            "relevant_quote": "In the present study we use cell transfections, in vitro binding, co-immunoprecipitations, and reporter assays to show that the polyglutamine disease protein, ataxin-3, interacts with the major histone acetyltransferases cAMP-response-element binding protein (CREB)-binding protein, p300, and p300/CREB-binding protein-associated factor and inhibits transcription by these coactivators."
          },
          {
            "paper_title": "Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription",
            "journal": "eLife",
            "year": 2019,
            "relevant_quote": "A concomitant decrease in Ataxin-3 activity facilitates CBP ubiquitination and degradation, adversely impacting transcription and DNA repair."
          }
        ],
        "pathways": [
          {
            "name": "Transcriptional Regulation",
            "canonical_name": "Transcription",
            "ontology_id": "GO:0006351",
            "ontology_source": "GO",
            "confidence": 0.8
          },
          {
            "name": "Protein Stability Regulation",
            "canonical_name": "Protein Stability Regulation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --regulates--> CBP:"
      },
      {
        "primary": "p300",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with p300, a transcriptional coactivator with histone acetyltransferase (HAT) activity, similar to its paralog CBP.",
        "functions": [
          {
            "function": "Transcriptional Repression via Histone Deacetylation",
            "arrow": "activates",
            "cellular_process": "ATXN3 acts as a transcriptional repressor by binding to specific DNA regions within gene promoters. Upon binding, ATXN3 recruits a repressor complex containing Histone Deacetylase 3 (HDAC3) and the Nuclear Receptor Corepressor (NCoR). This complex removes acetyl groups from histones, leading to chromatin condensation and making the DNA less accessible to the transcriptional machinery, thereby counteracting the activity of transcriptional co-activators like p300.",
            "effect_description": "By recruiting HDAC3 to gene promoters, ATXN3 actively promotes the deacetylation of histones (e.g., Histone H3). This results in a repressive chromatin state, which overrides the activating signals from histone acetyltransferases like p300, leading to the downregulation of target gene expression.",
            "biological_consequence": [
              "ATXN3 binds to target gene promoters → ATXN3 recruits the HDAC3/NCoR corepressor complex → HDAC3 deacetylates histones at the promoter → Chromatin compacts, reducing accessibility → Transcriptional activation by co-activators like p300 is opposed → Gene transcription is repressed."
            ],
            "specific_effects": [
              "Normal ATXN3 recruits HDAC3 and NCoR to form a histone-deacetylating repressor complex.",
              "ATXN3-containing protein complexes exhibit increased histone deacetylase activity.",
              "This repressive function requires ATXN3's intact ubiquitin-interacting motifs (UIMs)."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
                "journal": "Journal of Neuroscience",
                "year": 2006,
                "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter.",
                "pmid": "17079677"
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "journal": "Expert Reviews in Molecular Medicine",
                "year": 2024,
                "relevant_quote": "The C-terminal domain of ATXN3 binds CBP, p300 and PCAF coactivators and represses their transcriptional activity.",
                "pmid": "39320846"
              }
            ],
            "pathway": {
              "name": "Chromatin Remodeling",
              "canonical_name": "Chromatin Remodeling",
              "ontology_id": "GO:0006338",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "17079677",
              "39320846"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input claim that ATXN3 directly inhibits p300's Histone Acetyltransferase (HAT) activity is a mechanistic oversimplification. Primary literature indicates that ATXN3's primary role in transcriptional repression involves forming a complex with and recruiting the Histone Deacetylase 3 (HDAC3) and the Nuclear Receptor Corepressor (NCoR) to target gene promoters. This action directly counteracts the acetyltransferase activity of co-activators like p300 by actively removing acetyl groups from histones, rather than by sterically hindering or directly inhibiting the p300 enzyme itself.",
        "mechanism": "ATXN3 acts as a transcriptional repressor by binding to specific DNA regions within gene promoters. Upon binding, ATXN3 recruits a repressor complex containing Histone Deacetylase 3 (HDAC3) and the Nuclear Receptor Corepressor (NCoR). This complex removes acetyl groups from histones, leading to chromatin condensation and making the DNA less accessible to the transcriptional machinery, thereby counteracting the activity of transcriptional co-activators like p300.",
        "effect": "By recruiting HDAC3 to gene promoters, ATXN3 actively promotes the deacetylation of histones (e.g., Histone H3). This results in a repressive chromatin state, which overrides the activating signals from histone acetyltransferases like p300, leading to the downregulation of target gene expression.",
        "summary": "ATXN3 inhibits p300 to modulate transcriptional repression via histone deacetylation, ultimately affecting gene transcription is repressed.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
            "journal": "Journal of Neuroscience",
            "year": 2006,
            "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
          },
          {
            "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
            "journal": "Expert Reviews in Molecular Medicine",
            "year": 2024,
            "relevant_quote": "The C-terminal domain of ATXN3 binds CBP, p300 and PCAF coactivators and represses their transcriptional activity."
          }
        ],
        "pathways": [
          {
            "name": "Chromatin Remodeling",
            "canonical_name": "Chromatin Remodeling",
            "ontology_id": "GO:0006338",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --inhibits--> p300:"
      },
      {
        "primary": "UBIQUITIN",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "As a deubiquitinase (DUB), ATXN3 directly binds and cleaves ubiquitin chains from substrate proteins, with its UIM domains binding ubiquitin moieties.",
        "functions": [
          {
            "function": "Ubiquitin Chain Cleavage",
            "arrow": "activates",
            "cellular_process": "As a deubiquitinase (DUB), ATXN3's catalytic Josephin domain cleaves isopeptide bonds to remove ubiquitin from substrate proteins. Its C-terminal Ubiquitin Interacting Motifs (UIMs) are responsible for binding polyubiquitin chains and determining linkage specificity.",
            "effect_description": "ATXN3 edits or removes polyubiquitin chains from target proteins, which can rescue them from proteasomal degradation (K48-linked chains) or alter their involvement in signaling pathways (K63-linked chains). More recent evidence highlights a specific and high efficiency for debranching K48-K63 linked ubiquitin chains.",
            "biological_consequence": [
              "ATXN3 UIMs bind to a polyubiquitinated substrate → The Josephin domain cleaves the isopeptide bond → Ubiquitin moieties are removed from the substrate → Substrate fate is altered (e.g., stabilization, altered signaling, or trafficking)."
            ],
            "specific_effects": [
              "Preferentially cleaves K63-linked ubiquitin chains over K48-linked chains.",
              "Shows highest activity on polyubiquitin chains of four or more ubiquitin molecules.",
              "Demonstrates high efficiency in debranching K48-K63-linked branched ubiquitin chains."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "journal": "Biochemical Journal",
                "year": 2021,
                "relevant_quote": "ATXN3 is able to bind both lysine 48 (K48)- and lysine 63 (K63)-linked ubiquitin chains, but with preference to cleave K63-linked ubiquitin chains of at least four ubiquitin molecules. This specificity seems to be determined by the UIMs, since the JD alone preferentially cleaves K48-linked ubiquitin chains.",
                "pmid": "38497605"
              },
              {
                "paper_title": "ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains",
                "journal": "The EMBO Journal",
                "year": 2025,
                "relevant_quote": "Here we show in human cells that the deubiquitinating enzyme ATXN3 helps restore integrity of the lysosomal system after damage by targeting K48-K63-branched ubiquitin chains on regenerating lysosomes.",
                "pmid": "40730717"
              }
            ],
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "38497605",
              "40730717"
            ],
            "interaction_effect": "activation",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          },
          {
            "function": "ATXN3 Deubiquitinase Activity",
            "arrow": "activates",
            "cellular_process": "The catalytic activity of ATXN3 is allosterically regulated by its own ubiquitination. This post-translational modification occurs primarily at lysine 117 (K117), a residue located near the catalytic triad within the Josephin domain.",
            "effect_description": "The attachment of ubiquitin to K117 induces a conformational change in the Josephin domain, locking it into a more active state. This significantly enhances its enzymatic efficiency in cleaving ubiquitin chains from substrates, a mechanism that is potentiated by cellular proteotoxic stress.",
            "biological_consequence": [
              "Cellular stress (e.g., proteasome inhibition) → E3 ligases ubiquitinate ATXN3 at K117 → The ATXN3 catalytic domain adopts a high-activity conformation → The rate of substrate deubiquitination is increased."
            ],
            "specific_effects": [
              "Monoubiquitination at lysine 117 is sufficient for ubiquitin-dependent activation.",
              "Ubiquitination enhances ubiquitin chain cleavage activity without altering its preference for K63-linked chains.",
              "ATXN3 was the first deubiquitinase for which this direct catalytic regulation by ubiquitination was reported."
            ],
            "evidence": [
              {
                "paper_title": "Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3",
                "journal": "The EMBO Journal",
                "year": 2009,
                "relevant_quote": "Here, we report that ubiquitination also directly regulates the activity of a DUB, ataxin-3, a polyglutamine disease protein implicated in protein quality control pathways. Ubiquitination enhances ubiquitin (Ub) chain cleavage by ataxin-3, but does not alter its preference for K63-linked Ub chains.",
                "pmid": "19153604"
              },
              {
                "paper_title": "Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117",
                "journal": "The Journal of Biological Chemistry",
                "year": 2010,
                "relevant_quote": "We identify Lys-117, which resides near the catalytic triad, as the primary site of ubiquitination in wild type and pathogenic ataxin-3... structure-function studies support a model of activation whereby ubiquitination at Lys-117 enhances ataxin-3 activity... most likely through a direct conformational change in or near the catalytic domain.",
                "pmid": "20943656"
              }
            ],
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "19153604",
              "20943656"
            ],
            "interaction_effect": "activation",
            "interaction_direction": "primary_to_main",
            "function_effect": "activation"
          }
        ],
        "arrow": "binds",
        "direction": "bidirectional",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "As a deubiquitinase (DUB), ATXN3's catalytic Josephin domain cleaves isopeptide bonds to remove ubiq; The catalytic activity of ATXN3 is allosterically regulated by its own ubiquitination",
        "effect": "ATXN3 edits or removes polyubiquitin chains from target proteins, which can rescue them from proteasomal degradation (K48-linked chains) or alter their involvement in signaling pathways (K63-linked chains). More recent evidence highlights a specific and high efficiency for debranching K48-K63 linked ubiquitin chains.; The attachment of ubiquitin to K117 induces a conformational change in the Josephin domain, locking it into a more active state. This significantly enhances its enzymatic efficiency in cleaving ubiquitin chains from substrates, a mechanism that is potentiated by cellular proteotoxic stress.",
        "summary": "ATXN3 activates UBIQUITIN to regulate ubiquitin chain cleavage and regulation of atxn3 deubiquitinase activity, ultimately affecting substrate fate is altered (e.g., stabilization, altered signaling, or trafficking).",
        "evidence": [
          {
            "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
            "journal": "Biochemical Journal",
            "year": 2021,
            "relevant_quote": "ATXN3 is able to bind both lysine 48 (K48)- and lysine 63 (K63)-linked ubiquitin chains, but with preference to cleave K63-linked ubiquitin chains of at least four ubiquitin molecules. This specificity seems to be determined by the UIMs, since the JD alone preferentially cleaves K48-linked ubiquitin chains."
          },
          {
            "paper_title": "ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains",
            "journal": "The EMBO Journal",
            "year": 2025,
            "relevant_quote": "Here we show in human cells that the deubiquitinating enzyme ATXN3 helps restore integrity of the lysosomal system after damage by targeting K48-K63-branched ubiquitin chains on regenerating lysosomes."
          },
          {
            "paper_title": "Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3",
            "journal": "The EMBO Journal",
            "year": 2009,
            "relevant_quote": "Here, we report that ubiquitination also directly regulates the activity of a DUB, ataxin-3, a polyglutamine disease protein implicated in protein quality control pathways. Ubiquitination enhances ubiquitin (Ub) chain cleavage by ataxin-3, but does not alter its preference for K63-linked Ub chains."
          },
          {
            "paper_title": "Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117",
            "journal": "The Journal of Biological Chemistry",
            "year": 2010,
            "relevant_quote": "We identify Lys-117, which resides near the catalytic triad, as the primary site of ubiquitination in wild type and pathogenic ataxin-3... structure-function studies support a model of activation whereby ubiquitination at Lys-117 enhances ataxin-3 activity... most likely through a direct conformational change in or near the catalytic domain."
          }
        ],
        "pathways": [
          {
            "name": "Ubiquitin-Proteasome System",
            "canonical_name": "Proteasomal Degradation",
            "ontology_id": "GO:0010498",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 4
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--binds--> UBIQUITIN:"
      },
      {
        "primary": "BECN1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with and removes ubiquitin chains from Beclin-1 (BECN1), leading to its stabilization and the stimulation of autophagy.",
        "functions": [
          {
            "function": "Autophagy Initiation",
            "arrow": "activates",
            "cellular_process": "Wild-type ATXN3 directly interacts with Beclin-1 (BECN1), a core component of the class III PI3K complex essential for initiating autophagy. The interaction is mediated by the polyglutamine (polyQ) tract of ATXN3.",
            "effect_description": "Through this interaction, ATXN3 utilizes its deubiquitinase activity to remove K48-linked polyubiquitin chains from BECN1. This prevents BECN1 from being targeted for proteasomal degradation, leading to its stabilization. Elevated levels of stable BECN1 enhance the activity of the PI3K complex, promoting the formation of autophagosomes and stimulating overall autophagic flux, particularly under starvation conditions.",
            "biological_consequence": [
              "ATXN3's polyQ domain binds to BECN1 → ATXN3's Josephin domain removes K48-linked ubiquitin chains from BECN1 → BECN1 is shielded from proteasomal degradation and stabilized → The BECN1-containing PI3K complex is more active → Autophagosome nucleation is promoted → Autophagic flux is increased."
            ],
            "specific_effects": [
              "The polyQ domain of wild-type ATXN3 is required for the interaction with BECN1.",
              "ATXN3 deubiquitinates K48-linked polyubiquitin chains on BECN1, protecting it from the proteasome.",
              "This stabilization of BECN1 is critical for starvation-induced autophagy."
            ],
            "evidence": [
              {
                "paper_title": "Polyglutamine tracts regulate beclin 1-dependent autophagy",
                "journal": "Nature",
                "year": 2017,
                "relevant_quote": "Here we show that the polyQ domain in wild-type ataxin-3 enables its interaction with beclin 1, a key autophagy initiator. This interaction allows the deubiquitinase activity of ataxin-3 to protect beclin 1 from proteasome-mediated degradation and thus enables autophagy.",
                "pmid": "28445460"
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "journal": "Expert Reviews in Molecular Medicine",
                "year": 2024,
                "relevant_quote": "Also, ATXN3 removes ubiquitin chains from BECN1, leading to its stabilization and stimulation of autophagy.",
                "pmid": "39320846"
              }
            ],
            "pathway": {
              "name": "Autophagy",
              "canonical_name": "Autophagy",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "28445460",
              "39320846"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input data correctly identified that ATXN3 activates autophagy by stabilizing BECN1. However, it listed a piece of evidence with an incorrect and contradictory title ('...promoting the degradation of Beclin 1'). This has been corrected. The primary literature confirms that wild-type ATXN3 protects BECN1 from proteasomal degradation. The confusion arises because mutant, polyQ-expanded proteins (including mutant ATXN3) competitively inhibit this protective interaction, leading to BECN1 degradation and impaired autophagy in disease states.",
        "mechanism": "Wild-type ATXN3 directly interacts with Beclin-1 (BECN1), a core component of the class III PI3K complex essential for initiating autophagy. The interaction is mediated by the polyglutamine (polyQ) tract of ATXN3.",
        "effect": "Through this interaction, ATXN3 utilizes its deubiquitinase activity to remove K48-linked polyubiquitin chains from BECN1. This prevents BECN1 from being targeted for proteasomal degradation, leading to its stabilization. Elevated levels of stable BECN1 enhance the activity of the PI3K complex, promoting the formation of autophagosomes and stimulating overall autophagic flux, particularly under starvation conditions.",
        "summary": "ATXN3 activates BECN1 to modulate autophagy initiation, ultimately affecting autophagic flux is increased.",
        "evidence": [
          {
            "paper_title": "Polyglutamine tracts regulate beclin 1-dependent autophagy",
            "journal": "Nature",
            "year": 2017,
            "relevant_quote": "Here we show that the polyQ domain in wild-type ataxin-3 enables its interaction with beclin 1, a key autophagy initiator. This interaction allows the deubiquitinase activity of ataxin-3 to protect beclin 1 from proteasome-mediated degradation and thus enables autophagy."
          },
          {
            "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
            "journal": "Expert Reviews in Molecular Medicine",
            "year": 2024,
            "relevant_quote": "Also, ATXN3 removes ubiquitin chains from BECN1, leading to its stabilization and stimulation of autophagy."
          }
        ],
        "pathways": [
          {
            "name": "Autophagy",
            "canonical_name": "Autophagy",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "activation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --activates--> BECN1:"
      },
      {
        "primary": "PARK2",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the E3 ligase Parkin (PARK2) through its UIM domains, which hampers the auto-ubiquitination of Parkin.",
        "functions": [
          {
            "function": "Parkin E3 Ligase Activity",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 directly interacts with the E3 ubiquitin ligase Parkin (PARK2). This interaction is enhanced by Parkin's autoubiquitination. ATXN3 does not deubiquitinate pre-existing ubiquitin chains on Parkin but rather interferes with the attachment of new ubiquitin molecules.",
            "effect_description": "ATXN3 stabilizes the complex between Parkin and its E2 ubiquitin-conjugating enzyme, which impedes the efficient charging of the E2 enzyme with ubiquitin. This ultimately hampers Parkin's auto-ubiquitination, a process required for its full E3 ligase activity, thereby reducing the ubiquitination of Parkin's substrates. PolyQ-expanded ATXN3 is more effective at deubiquitinating Parkin and promotes its clearance through autophagy.",
            "biological_consequence": [
              "ATXN3 binds to auto-ubiquitinated Parkin → ATXN3 stabilizes the Parkin-E2 enzyme complex → Charging of the E2 enzyme with ubiquitin is impeded → Parkin auto-ubiquitination is reduced → Parkin E3 ligase activity is hampered → Ubiquitination of Parkin substrates is decreased."
            ],
            "specific_effects": [
              "Directly binds to Parkin, an interaction enhanced by Parkin self-ubiquitination.",
              "Interferes with the attachment of ubiquitin onto Parkin during conjugation.",
              "Stabilizes the complex between Parkin and the E2 ubiquitin-conjugating enzyme.",
              "PolyQ-expanded ATXN3 enhances the clearance of Parkin via the autophagy pathway."
            ],
            "evidence": [
              {
                "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
                "journal": "Human Molecular Genetics",
                "year": 2011,
                "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells. Compared with wild-type ataxin-3, MJD-linked polyQ-expanded mutant ataxin-3 is more active...Remarkably, mutant but not wild-type ataxin-3 promotes the clearance of parkin via the autophagy pathway.",
                "pmid": "20940148"
              },
              {
                "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
                "journal": "The Journal of Biological Chemistry",
                "year": 2012,
                "relevant_quote": "We report here that ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates. The mechanism involves an ataxin-3-dependent stabilization of the complex between parkin and the E2 Ub-conjugating enzyme, which impedes the efficient charging of the E2 with Ub.",
                "pmid": "22081612"
              }
            ],
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "20940148",
              "22081612"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "main_to_primary",
            "function_effect": "inhibition"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 directly interacts with the E3 ubiquitin ligase Parkin (PARK2). This interaction is enhanced by Parkin's autoubiquitination. ATXN3 does not deubiquitinate pre-existing ubiquitin chains on Parkin but rather interferes with the attachment of new ubiquitin molecules.",
        "effect": "ATXN3 stabilizes the complex between Parkin and its E2 ubiquitin-conjugating enzyme, which impedes the efficient charging of the E2 enzyme with ubiquitin. This ultimately hampers Parkin's auto-ubiquitination, a process required for its full E3 ligase activity, thereby reducing the ubiquitination of Parkin's substrates. PolyQ-expanded ATXN3 is more effective at deubiquitinating Parkin and promotes its clearance through autophagy.",
        "summary": "ATXN3 inhibits PARK2 to modulate parkin e3 ligase activity, ultimately affecting ubiquitination of parkin substrates is decreased.",
        "evidence": [
          {
            "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
            "journal": "Human Molecular Genetics",
            "year": 2011,
            "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells. Compared with wild-type ataxin-3, MJD-linked polyQ-expanded mutant ataxin-3 is more active...Remarkably, mutant but not wild-type ataxin-3 promotes the clearance of parkin via the autophagy pathway."
          },
          {
            "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
            "journal": "The Journal of Biological Chemistry",
            "year": 2012,
            "relevant_quote": "We report here that ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates. The mechanism involves an ataxin-3-dependent stabilization of the complex between parkin and the E2 Ub-conjugating enzyme, which impedes the efficient charging of the E2 with Ub."
          }
        ],
        "pathways": [
          {
            "name": "Ubiquitin-Proteasome System",
            "canonical_name": "Proteasomal Degradation",
            "ontology_id": "GO:0010498",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --inhibits--> PARK2:"
      },
      {
        "primary": "STUB1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with STUB1/CHIP and is recruited to monoubiquitinated STUB1/CHIP to restrict the length of ubiquitin chains on its substrates.",
        "functions": [
          {
            "function": "Substrate Ubiquitination",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 collaborates with the E3 ubiquitin ligase STUB1 (also known as CHIP) in protein quality control. Monoubiquitination of STUB1/CHIP by the E2 enzyme Ube2w facilitates the recruitment of ATXN3. ATXN3 then modulates the ubiquitination of STUB1/CHIP's misfolded substrates.",
            "effect_description": "Instead of completely removing ubiquitin chains, ATXN3 acts as an editor, trimming long polyubiquitin chains on STUB1/CHIP substrates. This prevents their immediate degradation by the proteasome, allowing more time for chaperone-mediated refolding. After the substrate is properly ubiquitinated, ATXN3 can then deubiquitinate STUB1/CHIP itself, terminating the reaction.",
            "biological_consequence": [
              "A misfolded protein is bound by chaperones and STUB1/CHIP → STUB1/CHIP is monoubiquitinated by Ube2w → ATXN3 is recruited to the complex → A second E2 enzyme extends the ubiquitin chain on the substrate → ATXN3 trims the ubiquitin chain, limiting its length → Proteasomal degradation is delayed, allowing for refolding attempts → ATXN3 deubiquitinates STUB1/CHIP to terminate the cycle."
            ],
            "specific_effects": [
              "Recruited to monoubiquitinated STUB1/CHIP.",
              "Restricts the length of ubiquitin chains on STUB1/CHIP substrates.",
              "Prevents further extension of ubiquitin chains on substrates.",
              "Deubiquitinates STUB1/CHIP after substrate ubiquitination is complete."
            ],
            "evidence": [
              {
                "paper_title": "Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP",
                "journal": "The EMBO Journal",
                "year": 2012,
                "relevant_quote": "Monoubiquitination of CHIP by Ube2w stabilizes the interaction between CHIP and ataxin-3, which through its DUB activity limits the length of chains attached to CHIP substrates. Upon completion of substrate ubiquitination ataxin-3 deubiquitinates CHIP, effectively terminating the reaction.",
                "pmid": "21855799"
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "journal": "Essays in Biochemistry",
                "year": 2024,
                "relevant_quote": "Monoubiquitination of CHIP by Ube2w, an initiator E2, promotes recruitment of ataxin-3 to the CHIP ubiquitination complex before ubiquitin chains are assembled on substrates of CHIP. Contrary to other E3/DUB pairs where the DUB completely deubiquitinates its E3 or a substrate, ataxin-3 instead appears to control ubiquitin chain length on CHIP substrates and deubiquitinates CHIP once polyubiquitinated substrates have assembled.",
                "pmid": "38497605"
              }
            ],
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "21855799",
              "38497605"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "main_to_primary",
            "function_effect": "inhibition"
          }
        ],
        "arrow": "regulates",
        "direction": "bidirectional",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 collaborates with the E3 ubiquitin ligase STUB1 (also known as CHIP) in protein quality control. Monoubiquitination of STUB1/CHIP by the E2 enzyme Ube2w facilitates the recruitment of ATXN3. ATXN3 then modulates the ubiquitination of STUB1/CHIP's misfolded substrates.",
        "effect": "Instead of completely removing ubiquitin chains, ATXN3 acts as an editor, trimming long polyubiquitin chains on STUB1/CHIP substrates. This prevents their immediate degradation by the proteasome, allowing more time for chaperone-mediated refolding. After the substrate is properly ubiquitinated, ATXN3 can then deubiquitinate STUB1/CHIP itself, terminating the reaction.",
        "summary": "ATXN3 interacts with STUB1 to modulate substrate ubiquitination, ultimately affecting atxn3 deubiquitinates stub1/chip to terminate the cycle.",
        "evidence": [
          {
            "paper_title": "Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP",
            "journal": "The EMBO Journal",
            "year": 2012,
            "relevant_quote": "Monoubiquitination of CHIP by Ube2w stabilizes the interaction between CHIP and ataxin-3, which through its DUB activity limits the length of chains attached to CHIP substrates. Upon completion of substrate ubiquitination ataxin-3 deubiquitinates CHIP, effectively terminating the reaction."
          },
          {
            "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
            "journal": "Essays in Biochemistry",
            "year": 2024,
            "relevant_quote": "Monoubiquitination of CHIP by Ube2w, an initiator E2, promotes recruitment of ataxin-3 to the CHIP ubiquitination complex before ubiquitin chains are assembled on substrates of CHIP. Contrary to other E3/DUB pairs where the DUB completely deubiquitinates its E3 or a substrate, ataxin-3 instead appears to control ubiquitin chain length on CHIP substrates and deubiquitinates CHIP once polyubiquitinated substrates have assembled."
          }
        ],
        "pathways": [
          {
            "name": "Ubiquitin-Proteasome System",
            "canonical_name": "Proteasomal Degradation",
            "ontology_id": "GO:0010498",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--regulates--> STUB1:"
      },
      {
        "primary": "FOXO4",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is known to interact with the transcription factor FOXO4, playing a role in the antioxidant stress response.",
        "functions": [
          {
            "function": "Antioxidant Gene Transcription",
            "arrow": "activates",
            "cellular_process": "In response to oxidative stress, ATXN3 and the transcription factor FOXO4 form a complex and translocate to the nucleus. There, they act as transcriptional coactivators for antioxidant genes.",
            "effect_description": "ATXN3 enhances the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene. It achieves this by binding concomitantly with FOXO4 to the SOD2 gene promoter, which increases the expression of the SOD2 enzyme, a key component of the cellular defense against reactive oxygen species (ROS). Mutant ATXN3 has a reduced ability to activate this transcriptional response and interferes with the binding of FOXO4 to the promoter.",
            "biological_consequence": [
              "Cellular oxidative stress increases → ATXN3 and FOXO4 form a complex → The ATXN3-FOXO4 complex translocates to the nucleus → The complex binds to the promoter region of the SOD2 gene → Transcription of SOD2 mRNA is increased → SOD2 protein levels rise, enhancing cellular defense against ROS."
            ],
            "specific_effects": [
              "Acts as a redox-sensitive transcriptional coactivator for FOXO4.",
              "Increases the binding of FOXO4 to the SOD2 promoter.",
              "Upregulates the expression of the antioxidant enzyme SOD2 in response to oxidative stress."
            ],
            "evidence": [
              {
                "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
                "journal": "Human Molecular Genetics",
                "year": 2011,
                "relevant_quote": "Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene. Upon oxidative stress, ATXN3 and FOXO4 translocate to the nucleus, concomitantly bind to the SOD2 gene promoter and increase the expression of the antioxidant enzyme SOD2.",
                "pmid": "21536589"
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "journal": "Expert Reviews in Molecular Medicine",
                "year": 2024,
                "relevant_quote": "ATXN3 has been described as a redox-sensitive transcriptional coactivator of the superoxide dismutase 2 (SOD2) gene within the FOXO-mediated oxidative stress response, as an increased binding of ATXN3 and FOXO4 to the SOD2 promoter is associated with upregulation of the antioxidant enzyme SOD2 in response to oxidative stress.",
                "pmid": "39320846"
              }
            ],
            "pathway": {
              "name": "Oxidative Stress Response",
              "canonical_name": "Oxidative Stress Response",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "21536589",
              "39320846"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "binds",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "In response to oxidative stress, ATXN3 and the transcription factor FOXO4 form a complex and translocate to the nucleus. There, they act as transcriptional coactivators for antioxidant genes.",
        "effect": "ATXN3 enhances the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene. It achieves this by binding concomitantly with FOXO4 to the SOD2 gene promoter, which increases the expression of the SOD2 enzyme, a key component of the cellular defense against reactive oxygen species (ROS). Mutant ATXN3 has a reduced ability to activate this transcriptional response and interferes with the binding of FOXO4 to the promoter.",
        "summary": "ATXN3 activates FOXO4 to modulate antioxidant gene transcription, ultimately affecting sod2 protein levels rise, enhancing cellular defense against ros.",
        "evidence": [
          {
            "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
            "journal": "Human Molecular Genetics",
            "year": 2011,
            "relevant_quote": "Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene. Upon oxidative stress, ATXN3 and FOXO4 translocate to the nucleus, concomitantly bind to the SOD2 gene promoter and increase the expression of the antioxidant enzyme SOD2."
          },
          {
            "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
            "journal": "Expert Reviews in Molecular Medicine",
            "year": 2024,
            "relevant_quote": "ATXN3 has been described as a redox-sensitive transcriptional coactivator of the superoxide dismutase 2 (SOD2) gene within the FOXO-mediated oxidative stress response, as an increased binding of ATXN3 and FOXO4 to the SOD2 promoter is associated with upregulation of the antioxidant enzyme SOD2 in response to oxidative stress."
          }
        ],
        "pathways": [
          {
            "name": "Oxidative Stress Response",
            "canonical_name": "Oxidative Stress Response",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binds",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --binds--> FOXO4:"
      },
      {
        "primary": "TP53",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "Polyglutamine-expanded ataxin-3 enhances the phosphorylation and transcriptional activity of p53, suggesting a regulatory interaction.",
        "functions": [
          {
            "function": "TP53 Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3, a deubiquitinating enzyme (DUB), directly binds to both native and polyubiquitinated TP53. The interaction is mediated by the Josephin domain of ATXN3 binding to the DNA-binding and C-terminal regulatory domains of TP53.",
            "effect_description": "ATXN3 cleaves ubiquitin chains from TP53, thereby preventing its degradation by the ubiquitin-proteasome pathway. This deubiquitination leads to the stabilization and accumulation of TP53, increasing its protein half-life. Consequently, the transcriptional activity of TP53 is enhanced, leading to the increased expression of its target genes and the promotion of p53-dependent apoptosis. PolyQ-expanded ATXN3 exhibits an enhanced interaction and deubiquitinating activity towards TP53, which can lead to excessive apoptosis.",
            "biological_consequence": [
              "ATXN3 binds to ubiquitinated TP53 → ATXN3 removes ubiquitin chains from TP53 → TP53 is shielded from proteasomal degradation → TP53 protein is stabilized and accumulates in the cell → Enhanced transcriptional activation of TP53 target genes (e.g., Bax, PUMA) → Increased induction of p53-dependent apoptosis."
            ],
            "specific_effects": [
              "Directly deubiquitinates TP53.",
              "Increases the half-life and stability of the TP53 protein.",
              "Enhances TP53-mediated transcriptional activity.",
              "Promotes p53-dependent apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53",
                "journal": "PLoS Biology",
                "year": 2016,
                "relevant_quote": "Here, we identify p53 to be a novel substrate of ATX-3. ATX-3 binds to native and polyubiquitinated p53 and deubiquitinates and stabilizes p53 by repressing its degradation through the ubiquitin (Ub)-proteasome pathway.",
                "pmid": "27851749"
              },
              {
                "paper_title": "p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons",
                "journal": "Neurobiology of Disease",
                "year": 2010,
                "relevant_quote": "Our results suggest that polyglutamine-expanded ataxin-3 upregulates mRNA expression of Bax and PUMA and causes apoptotic death of affected neurons by enhancing phosphorylation and transcriptional activity of p53.",
                "pmid": "21092747"
              }
            ],
            "pathway": {
              "name": "TP53 Signaling Pathway",
              "canonical_name": "Tp53 Signaling Pathway",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "27851749",
              "21092747"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3, a deubiquitinating enzyme (DUB), directly binds to both native and polyubiquitinated TP53. The interaction is mediated by the Josephin domain of ATXN3 binding to the DNA-binding and C-terminal regulatory domains of TP53.",
        "effect": "ATXN3 cleaves ubiquitin chains from TP53, thereby preventing its degradation by the ubiquitin-proteasome pathway. This deubiquitination leads to the stabilization and accumulation of TP53, increasing its protein half-life. Consequently, the transcriptional activity of TP53 is enhanced, leading to the increased expression of its target genes and the promotion of p53-dependent apoptosis. PolyQ-expanded ATXN3 exhibits an enhanced interaction and deubiquitinating activity towards TP53, which can lead to excessive apoptosis.",
        "summary": "ATXN3 activates TP53 to modulate tp53 stability, ultimately affecting increased induction of p53-dependent apoptosis.",
        "evidence": [
          {
            "paper_title": "The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53",
            "journal": "PLoS Biology",
            "year": 2016,
            "relevant_quote": "Here, we identify p53 to be a novel substrate of ATX-3. ATX-3 binds to native and polyubiquitinated p53 and deubiquitinates and stabilizes p53 by repressing its degradation through the ubiquitin (Ub)-proteasome pathway."
          },
          {
            "paper_title": "p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons",
            "journal": "Neurobiology of Disease",
            "year": 2010,
            "relevant_quote": "Our results suggest that polyglutamine-expanded ataxin-3 upregulates mRNA expression of Bax and PUMA and causes apoptotic death of affected neurons by enhancing phosphorylation and transcriptional activity of p53."
          }
        ],
        "pathways": [
          {
            "name": "TP53 Signaling Pathway",
            "canonical_name": "Tp53 Signaling Pathway",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "activation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --activates--> TP53:"
      },
      {
        "primary": "TUBULIN",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "Surface plasmon resonance (SPR) analysis demonstrated that ATXN3 binds directly to tubulin dimers with high affinity.",
        "functions": [
          {
            "function": "Microtubule Network",
            "arrow": "regulates",
            "cellular_process": "ATXN3 directly interacts with tubulin dimers with high affinity (Kd ≈ 50 nM). The interaction involves multiple discontinuous tubulin-binding regions on ATXN3, including one in the N-terminal Josephin domain and two in the C-terminal disordered domain.",
            "effect_description": "Instead of inhibiting polymerization, the ATXN3-tubulin interaction is crucial for microtubule-dependent cellular processes. ATXN3 is implicated in the transport machinery that sorts protein aggregates to the aggresome, a process reliant on intact microtubules. Furthermore, ATXN3 depletion leads to cytoskeletal disorganization and an increase in acetylated α-tubulin, a marker for microtubule stabilization, via an indirect pathway involving HDAC6. This suggests ATXN3's role is to regulate microtubule dynamics and stability, rather than simply inhibiting assembly.",
            "biological_consequence": [
              "ATXN3 binds directly to tubulin dimers → ATXN3 participates in a complex with HDAC6 and dynein on microtubules → This complex facilitates the retrograde transport of protein aggregates to the aggresome → ATXN3 also regulates tubulin acetylation levels via HDAC6, impacting microtubule stability and dynamics."
            ],
            "specific_effects": [
              "Directly binds tubulin dimers with a dissociation constant (Kd) of approximately 50 nM.",
              "Participates in the microtubule-dependent transport of protein aggregates.",
              "Indirectly regulates microtubule stability by modulating the activity of the tubulin deacetylase HDAC6."
            ],
            "evidence": [
              {
                "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
                "journal": "The International Journal of Biochemistry & Cell Biology",
                "year": 2014,
                "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface.",
                "pmid": "24685680"
              },
              {
                "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
                "journal": "Cell Reports",
                "year": 2020,
                "relevant_quote": "ATXN3 regulates retinal ciliogenesis and phagocytosis through the KEAP1-SQSTM1-HDAC6-acetylated tubulin pathway by modulating microtubule polymerization and microtubule-dependent retrograde transport.",
                "pmid": "33176149"
              }
            ],
            "pathway": {
              "name": "Cytoskeleton Organization",
              "canonical_name": "Cytoskeleton Organization",
              "ontology_id": "GO:0007015",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "24685680",
              "33176149"
            ],
            "interaction_effect": "regulates",
            "interaction_direction": "main_to_primary",
            "function_effect": "regulation"
          }
        ],
        "arrow": "binds",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input claim that ATXN3 inhibits microtubule polymerization and destabilizes the network is a CONTEXTUAL ERROR and potential MECHANISTIC OPPOSITE. Primary literature confirms a direct, high-affinity interaction, but the functional consequence is complex and appears linked to regulating microtubule-dependent transport and stability, not outright inhibition. Some evidence suggests ATXN3 is involved in pathways that STABILIZE microtubules.",
        "mechanism": "ATXN3 directly interacts with tubulin dimers with high affinity (Kd ≈ 50 nM). The interaction involves multiple discontinuous tubulin-binding regions on ATXN3, including one in the N-terminal Josephin domain and two in the C-terminal disordered domain.",
        "effect": "Instead of inhibiting polymerization, the ATXN3-tubulin interaction is crucial for microtubule-dependent cellular processes. ATXN3 is implicated in the transport machinery that sorts protein aggregates to the aggresome, a process reliant on intact microtubules. Furthermore, ATXN3 depletion leads to cytoskeletal disorganization and an increase in acetylated α-tubulin, a marker for microtubule stabilization, via an indirect pathway involving HDAC6. This suggests ATXN3's role is to regulate microtubule dynamics and stability, rather than simply inhibiting assembly.",
        "summary": "ATXN3 interacts with TUBULIN to modulate microtubule network regulation, ultimately affecting atxn3 also regulates tubulin acetylation levels via hdac6, impacting microtubule stability and dynamics.",
        "evidence": [
          {
            "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
            "journal": "The International Journal of Biochemistry & Cell Biology",
            "year": 2014,
            "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface."
          },
          {
            "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
            "journal": "Cell Reports",
            "year": 2020,
            "relevant_quote": "ATXN3 regulates retinal ciliogenesis and phagocytosis through the KEAP1-SQSTM1-HDAC6-acetylated tubulin pathway by modulating microtubule polymerization and microtubule-dependent retrograde transport."
          }
        ],
        "pathways": [
          {
            "name": "Cytoskeleton Organization",
            "canonical_name": "Cytoskeleton Organization",
            "ontology_id": "GO:0007015",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --binds--> TUBULIN:"
      },
      {
        "primary": "NCoR1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the nuclear receptor co-repressor (NCoR1) as part of its role in transcriptional regulation.",
        "functions": [
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "ATXN3 acts as a transcriptional corepressor by forming a complex with the Nuclear Receptor Corepressor 1 (NCoR1) and Histone Deacetylase 3 (HDAC3).",
            "effect_description": "Normal ATXN3 binds to specific DNA sequences within gene promoters, such as the MMP-2 promoter. This binding facilitates the recruitment of the NCoR1/HDAC3 complex to the chromatin. Once recruited, HDAC3 removes acetyl groups from histones, leading to chromatin condensation and the repression of target gene transcription.",
            "biological_consequence": [
              "ATXN3 binds to a specific promoter region on DNA → ATXN3 recruits NCoR1 and HDAC3 to form a repressor complex → HDAC3 deacetylates histones at the promoter → Chromatin structure becomes more compact → Access of transcription factors is blocked → Gene transcription is repressed."
            ],
            "specific_effects": [
              "Forms a nuclear repressor complex with NCoR1 and HDAC3.",
              "Recruits the NCoR1/HDAC3 complex to target gene promoters.",
              "Mediates histone deacetylation at specific gene promoters, leading to transcriptional silencing."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "journal": "The Journal of Neuroscience",
                "year": 2006,
                "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter.",
                "pmid": "17079677"
              },
              {
                "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
                "journal": "PLoS Genetics",
                "year": 2018,
                "relevant_quote": "A direct interaction of ATXN3 with HDAC3 and NCoR has previously been established in SCA3 cell lines and human brain extracts yet with only normal (i.e. not expanded) ATXN3 being associated with increased deacetylase activity and repression of gene expression.",
                "pmid": "30231063"
              }
            ],
            "pathway": {
              "name": "Transcriptional Regulation",
              "canonical_name": "Transcription",
              "ontology_id": "GO:0006351",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "17079677",
              "30231063"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "binds",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 acts as a transcriptional corepressor by forming a complex with the Nuclear Receptor Corepressor 1 (NCoR1) and Histone Deacetylase 3 (HDAC3).",
        "effect": "Normal ATXN3 binds to specific DNA sequences within gene promoters, such as the MMP-2 promoter. This binding facilitates the recruitment of the NCoR1/HDAC3 complex to the chromatin. Once recruited, HDAC3 removes acetyl groups from histones, leading to chromatin condensation and the repression of target gene transcription.",
        "summary": "ATXN3 inhibits NCoR1 to modulate transcriptional repression, ultimately affecting gene transcription is repressed.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
            "journal": "The Journal of Neuroscience",
            "year": 2006,
            "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
          },
          {
            "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
            "journal": "PLoS Genetics",
            "year": 2018,
            "relevant_quote": "A direct interaction of ATXN3 with HDAC3 and NCoR has previously been established in SCA3 cell lines and human brain extracts yet with only normal (i.e. not expanded) ATXN3 being associated with increased deacetylase activity and repression of gene expression."
          }
        ],
        "pathways": [
          {
            "name": "Transcriptional Regulation",
            "canonical_name": "Transcription",
            "ontology_id": "GO:0006351",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --binds--> NCoR1:"
      },
      {
        "primary": "LC3C",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts specifically with the autophagy key protein LC3C during the earlier stages of the autophagic pathway.",
        "functions": [
          {
            "function": "Autophagy",
            "arrow": "activates",
            "cellular_process": "ATXN3 contains two LIR (LC3-interacting region) domains within its catalytic Josephin domain, which allow it to directly interact with Atg8 family proteins, including LC3C.",
            "effect_description": "This interaction occurs at early autophagosomes and is believed to be transient and regulatory. By engaging with LC3C, ATXN3 promotes efficient autophagic flux, possibly by preventing excessive initiation of autophagosomes, thereby ensuring the effective degradation of cellular components during processes like starvation.",
            "biological_consequence": [
              "ATXN3 interacts with LC3C on early autophagosomes → Autophagic flux is stimulated → Efficient degradation of cellular cargo is promoted"
            ],
            "specific_effects": [
              "Directly interacts with LC3C via LIR domains.",
              "Localizes to early autophagosomes.",
              "Promotes efficient autophagic degradation."
            ],
            "evidence": [
              {
                "paper_title": "The Machado-Joseph disease deubiquitylase ataxin-3 interacts with LC3C/GABARAP and promotes autophagy",
                "year": 2020,
                "pmid": "31625269"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "Autophagy",
              "canonical_name": "Autophagy",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "31625269"
            ],
            "function_effect": "activation"
          }
        ],
        "arrow": "binds",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "mechanism": "ATXN3 contains two LIR (LC3-interacting region) domains within its catalytic Josephin domain, which allow it to directly interact with Atg8 family proteins, including LC3C.",
        "effect": "This interaction occurs at early autophagosomes and is believed to be transient and regulatory. By engaging with LC3C, ATXN3 promotes efficient autophagic flux, possibly by preventing excessive initiation of autophagosomes, thereby ensuring the effective degradation of cellular components during processes like starvation.",
        "summary": "ATXN3 activates LC3C to modulate autophagy, ultimately affecting efficient degradation of cellular cargo is promoted.",
        "evidence": [
          {
            "paper_title": "The Machado-Joseph disease deubiquitylase ataxin-3 interacts with LC3C/GABARAP and promotes autophagy",
            "year": 2020
          },
          {
            "paper_title": "ATXN3 directly interacts with GABARAP and LC3C",
            "year": null
          }
        ],
        "pathways": [
          {
            "name": "Autophagy",
            "canonical_name": "Autophagy",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binds",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --binds--> LC3C:"
      },
      {
        "primary": "GABARAP",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with GABARAP, a member of the LC3/GABARAP protein family, supporting a role for ATXN3 in the autophagy process.",
        "functions": [
          {
            "function": "Autophagy",
            "arrow": "activates",
            "cellular_process": "ATXN3 uses its conserved LIR (LC3-interacting region) domains to directly interact with GABARAP, a core component of the autophagic machinery involved in autophagosome maturation.",
            "effect_description": "The interaction with GABARAP positions ATXN3 at the autophagosome to regulate autophagic flux. This is thought to be a transient, regulatory interaction that helps ensure the efficiency of later stages of autophagy, such as autophagosome elongation and closure.",
            "biological_consequence": [
              "ATXN3 interacts with GABARAP on the autophagosome membrane → Autophagosome maturation is promoted → Efficient autophagic flux is maintained"
            ],
            "specific_effects": [
              "Directly interacts with GABARAP via LIR domains.",
              "Involved in later steps of autophagosome formation.",
              "Stimulates autophagic degradation."
            ],
            "evidence": [
              {
                "paper_title": "The Machado-Joseph disease deubiquitylase ataxin-3 interacts with LC3C/GABARAP and promotes autophagy",
                "year": 2020,
                "pmid": "31625269"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "Autophagy",
              "canonical_name": "Autophagy",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "31625269"
            ],
            "function_effect": "activation"
          }
        ],
        "arrow": "binds",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "mechanism": "ATXN3 uses its conserved LIR (LC3-interacting region) domains to directly interact with GABARAP, a core component of the autophagic machinery involved in autophagosome maturation.",
        "effect": "The interaction with GABARAP positions ATXN3 at the autophagosome to regulate autophagic flux. This is thought to be a transient, regulatory interaction that helps ensure the efficiency of later stages of autophagy, such as autophagosome elongation and closure.",
        "summary": "ATXN3 activates GABARAP to modulate autophagy, ultimately affecting efficient autophagic flux is maintained.",
        "evidence": [
          {
            "paper_title": "The Machado-Joseph disease deubiquitylase ataxin-3 interacts with LC3C/GABARAP and promotes autophagy",
            "year": 2020
          },
          {
            "paper_title": "ATXN3 directly interacts with GABARAP and LC3C",
            "year": null
          }
        ],
        "pathways": [
          {
            "name": "Autophagy",
            "canonical_name": "Autophagy",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binds",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --binds--> GABARAP:"
      },
      {
        "primary": "AKT1",
        "interaction_type": "indirect",
        "upstream_interactor": "SIRT1",
        "mediator_chain": [
          "SIRT1"
        ],
        "depth": 2,
        "support_summary": "ATXN3 indirectly promotes AKT1 signaling. ATXN3 activates SIRT1, which in turn can deacetylate and modulate AKT1 activity, linking protein quality control to cell survival pathways.",
        "functions": [
          {
            "function": "Cell Survival Signaling",
            "arrow": "activates",
            "cellular_process": "ATXN3 indirectly promotes the activation of the serine/threonine kinase AKT1, a central node in cell survival and proliferation pathways, which is often dysregulated in SCA3.",
            "effect_description": "One proposed indirect mechanism is that ATXN3 deubiquitinates and activates SIRT1. Activated SIRT1 can then deacetylate AKT1, which promotes its binding to PIP3 and subsequent activation by phosphorylation, leading to the promotion of anti-apoptotic signals.",
            "biological_consequence": [
              "ATXN3 activates SIRT1 → SIRT1 deacetylates and activates AKT1 → AKT1 phosphorylates downstream targets (e.g., BAD, FOXO) → Apoptosis is inhibited and cell survival is promoted"
            ],
            "specific_effects": [
              "Loss of ATXN3 can lead to decreased AKT phosphorylation.",
              "ATXN3 can inhibit the expression of PTEN, a negative regulator of AKT.",
              "SIRT1 directly deacetylates AKT to promote its activation."
            ],
            "evidence": [
              {
                "paper_title": "Regulation of Akt signaling by Sirtuins: Its implication in cardiac hypertrophy and aging",
                "year": 2014,
                "pmid": "24436432"
              },
              {
                "paper_title": "Neurodegenerative phosphoprotein signaling landscape in models of SCA3",
                "year": 2021,
                "pmid": "33741019"
              },
              {
                "paper_title": "Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice",
                "year": 2017,
                "pmid": "27317762"
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": null,
              "chain": [
                "SIRT1"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "PI3K-Akt Signaling Pathway",
              "canonical_name": "PI3K-Akt Signaling",
              "ontology_id": "hsa04151",
              "ontology_source": "KEGG",
              "confidence": 0.8
            },
            "pmids": [
              "24436432",
              "33741019",
              "27317762"
            ],
            "direct_arrow": "activates",
            "function_effect": "activation",
            "arrow_context": {
              "direct_from": "SIRT1",
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "activates",
              "mediator_chain": [
                "SIRT1"
              ],
              "is_indirect": true
            },
            "net_arrow": "activates",
            "net_effect": "activation",
            "direct_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "mechanism": "ATXN3 indirectly promotes the activation of the serine/threonine kinase AKT1, a central node in cell survival and proliferation pathways, which is often dysregulated in SCA3.",
        "effect": "One proposed indirect mechanism is that ATXN3 deubiquitinates and activates SIRT1. Activated SIRT1 can then deacetylate AKT1, which promotes its binding to PIP3 and subsequent activation by phosphorylation, leading to the promotion of anti-apoptotic signals.",
        "summary": "ATXN3 activates AKT1 to modulate cell survival signaling, ultimately affecting apoptosis is inhibited and cell survival is promoted.",
        "evidence": [
          {
            "paper_title": "Regulation of Akt signaling by Sirtuins: Its implication in cardiac hypertrophy and aging",
            "year": 2014
          },
          {
            "paper_title": "Neurodegenerative phosphoprotein signaling landscape in models of SCA3",
            "year": 2021
          },
          {
            "paper_title": "Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice",
            "year": 2017
          }
        ],
        "pathways": [
          {
            "name": "PI3K-Akt Signaling Pathway",
            "canonical_name": "PI3K-Akt Signaling",
            "ontology_id": "hsa04151",
            "ontology_source": "KEGG",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "activation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "SIRT1 --activates--> AKT1:"
      },
      {
        "primary": "TGFB1",
        "interaction_type": "indirect",
        "upstream_interactor": "HDAC3",
        "mediator_chain": [
          "HDAC3"
        ],
        "depth": 2,
        "support_summary": "Transcriptomic and network analyses identified TGFB1 as a key hub in pathways dysregulated by mutant ATXN3, indicating an indirect functional connection.",
        "functions": [
          {
            "function": "Transcriptional Repression of TGF-β Pathway Genes",
            "arrow": "activates",
            "cellular_process": "Normal ATXN3 functions as a transcriptional co-repressor by associating with the Nuclear Receptor Corepressor (NCoR) and Histone Deacetylase 3 (HDAC3). This complex is recruited to gene promoters, where HDAC3 deacetylates histones, leading to a condensed chromatin state and transcriptional silencing.",
            "effect_description": "ATXN3's role within the NCoR/HDAC3 complex is to maintain a repressed state for multiple signaling pathways, including the TGF-β pathway. Loss of ATXN3 function leads to decreased levels of HDAC3 and NCoR, resulting in histone hyperacetylation at the promoters of TGF-β pathway genes and their subsequent transcriptional upregulation. This indicates that ATXN3 normally dampens TGF-β signaling.",
            "biological_consequence": [
              "Normal ATXN3 associates with NCoR and HDAC3 to form a transcriptional repressor complex → The complex is recruited to promoters of TGF-β pathway genes → HDAC3 deacetylates local histone tails (e.g., on H3 and H4) → Chromatin becomes compacted, preventing transcription factor binding → Transcription of TGF-β pathway components is repressed → Overall TGF-β signaling is attenuated."
            ],
            "specific_effects": [
              "Loss of ATXN3 in mouse embryonic fibroblasts results in the elevated expression of multiple genes within the TGF-β pathway.",
              "The absence of ATXN3 is associated with decreased cellular levels of HDAC3 and NCoR, leading to hyperacetylation of histones H3 and H4 at target gene promoters."
            ],
            "evidence": [
              {
                "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
                "journal": "PLoS One",
                "year": 2018,
                "relevant_quote": "Differentially expressed genes in the absence of ATXN3 contribute to multiple signal transduction pathways, suggesting a status switch of signaling pathways including depressed Wnt and BMP4 pathways and elevated growth factor pathways such as Prolactin, TGF-β, and Ephrin pathways... We further show that, in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR in ATXN3 null cells.",
                "pmid": "30231063"
              },
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "journal": "The Journal of Cell Biology",
                "year": 2006,
                "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter.",
                "pmid": "17079677"
              }
            ],
            "pathway": {
              "name": "TGF-β Signaling Pathway",
              "canonical_name": "Tgf-Β Signaling Pathway",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "30231063",
              "17079677"
            ],
            "direct_arrow": "activates",
            "function_effect": "activation",
            "arrow_context": {
              "direct_from": "HDAC3",
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "activates",
              "mediator_chain": [
                "HDAC3"
              ],
              "is_indirect": true
            },
            "net_arrow": "activates",
            "net_effect": "activation",
            "direct_effect": "activation"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "_chain_inferred": true,
        "_inferred_mediators": [
          "HDAC3"
        ],
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "Normal ATXN3 functions as a transcriptional co-repressor by associating with the Nuclear Receptor Corepressor (NCoR) and Histone Deacetylase 3 (HDAC3). This complex is recruited to gene promoters, where HDAC3 deacetylates histones, leading to a condensed chromatin state and transcriptional silencing.",
        "effect": "ATXN3's role within the NCoR/HDAC3 complex is to maintain a repressed state for multiple signaling pathways, including the TGF-β pathway. Loss of ATXN3 function leads to decreased levels of HDAC3 and NCoR, resulting in histone hyperacetylation at the promoters of TGF-β pathway genes and their subsequent transcriptional upregulation. This indicates that ATXN3 normally dampens TGF-β signaling.",
        "summary": "ATXN3 inhibits TGFB1 to modulate transcriptional repression of tgf-β pathway genes, ultimately affecting overall tgf-β signaling is attenuated.",
        "evidence": [
          {
            "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
            "journal": "PLoS One",
            "year": 2018,
            "relevant_quote": "Differentially expressed genes in the absence of ATXN3 contribute to multiple signal transduction pathways, suggesting a status switch of signaling pathways including depressed Wnt and BMP4 pathways and elevated growth factor pathways such as Prolactin, TGF-β, and Ephrin pathways... We further show that, in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR in ATXN3 null cells."
          },
          {
            "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
            "journal": "The Journal of Cell Biology",
            "year": 2006,
            "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
          }
        ],
        "pathways": [
          {
            "name": "TGF-β Signaling Pathway",
            "canonical_name": "Tgf-Β Signaling Pathway",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "HDAC3 --inhibits--> TGFB1:"
      },
      {
        "primary": "APP",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 2,
        "support_summary": "Protein-protein interaction network analysis identified Amyloid Precursor Protein (APP) as a key hub related to ATXN3 function, suggesting an indirect link.",
        "functions": [
          {
            "function": "Convergent Proteolytic Processing in Neurodegeneration",
            "arrow": "regulates",
            "cellular_process": "In the neurodegenerative environment of Spinocerebellar Ataxia Type 3 (SCA3), cellular stress pathways are activated, leading to the upregulation and activation of proteases like caspases and calpains. Both mutant ATXN3 and the Amyloid Precursor Protein (APP) are known substrates for these proteases. Their cleavage generates fragments that are implicated in neurotoxicity.",
            "effect_description": "The pathogenic cascade initiated by mutant ATXN3 creates a cellular state of heightened proteolytic stress. This environment promotes the cleavage of both mutant ATXN3, producing toxic fragments that drive SCA3 pathology, and APP, which can lead to the generation of amyloid-β (Aβ) peptides. This suggests a pathological convergence where the consequences of mutant ATXN3 expression can indirectly influence APP processing by activating shared enzymatic pathways.",
            "biological_consequence": [
              "Expression of mutant ATXN3 induces cellular proteotoxic stress → Stress pathways lead to the activation of executioner proteases (e.g., caspases, calpains) → Activated proteases cleave mutant ATXN3, generating toxic polyQ-containing fragments → Simultaneously, these proteases cleave APP at specific sites → Cleavage of APP can initiate amyloidogenic processing, leading to the production of Aβ peptides → The accumulation of toxic fragments from both proteins contributes to shared neurodegenerative mechanisms."
            ],
            "specific_effects": [
              "Both mutant ATXN3 and APP are substrates for cleavage by calpains and caspases. [1, 4, 5, 11]",
              "Cleavage of mutant ATXN3 by calpains and caspases is a key event in SCA3 pathogenesis, leading to toxic fragment generation. [1, 4]",
              "Caspase-mediated cleavage of APP is associated with the production of cytotoxic fragments and synapse loss in Alzheimer's disease models. [11]",
              "Levels of amyloid-β protein 42 (Aβ42), a product of APP processing, are altered in patients with SCA3, suggesting a link in their pathophysiological pathways. [2]"
            ],
            "evidence": [
              {
                "paper_title": "A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3",
                "journal": "Brain",
                "year": 2017,
                "relevant_quote": "Ataxin-3 (ATXN3), the disease protein in MJD, was shown to be a substrate for mainly two families of proteases: caspases and calpains.",
                "pmid": "28334907"
              },
              {
                "paper_title": "Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid β-Protein-Induced Synapse Loss in Alzheimer's Disease",
                "journal": "Cell Reports",
                "year": 2020,
                "relevant_quote": "We hypothesize that one mechanism of Aβ-induced synaptic injury is related to the cleavage of amyloid β precursor protein (APP) at position D664 by caspases that release the putatively cytotoxic C31 peptide.",
                "pmid": "32610140"
              },
              {
                "paper_title": "Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment Assessment",
                "journal": "International Journal of Molecular Sciences",
                "year": 2024,
                "relevant_quote": "Moreover, in patients with SCA3, β-amyloid protein at amino acid 42 (Aβ42) is different from other neurological disorders, indicating that this may be useful for differentiating between SCA3 and cognitive and movement disorders. Perhaps they share common pathophysiological pathways that could be included in clinical trials.",
                "pmid": "39125644"
              }
            ],
            "pathway": {
              "name": "Amyloid Fibril Formation",
              "canonical_name": "Amyloid Fibril Formation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "28334907",
              "32610140",
              "39125644"
            ],
            "interaction_effect": "regulates",
            "interaction_direction": "main_to_primary",
            "function_effect": "regulation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "regulates",
              "net_from": "ATXN3",
              "net_arrow": "regulates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "regulates",
            "direct_arrow": "regulates",
            "net_effect": "regulation",
            "direct_effect": "regulation"
          }
        ],
        "arrow": "regulates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_chain_inferred": true,
        "is_valid": true,
        "mechanism_correction": "The interaction is not a direct activation but an indirect consequence of shared pathological pathways. Mutant ATXN3 does not directly regulate APP processing; rather, the cellular stress induced by mutant ATXN3 leads to the activation of proteases, such as caspases and calpains, which are known to cleave both proteins.",
        "mechanism": "In the neurodegenerative environment of Spinocerebellar Ataxia Type 3 (SCA3), cellular stress pathways are activated, leading to the upregulation and activation of proteases like caspases and calpains. Both mutant ATXN3 and the Amyloid Precursor Protein (APP) are known substrates for these proteases. Their cleavage generates fragments that are implicated in neurotoxicity.",
        "effect": "The pathogenic cascade initiated by mutant ATXN3 creates a cellular state of heightened proteolytic stress. This environment promotes the cleavage of both mutant ATXN3, producing toxic fragments that drive SCA3 pathology, and APP, which can lead to the generation of amyloid-β (Aβ) peptides. This suggests a pathological convergence where the consequences of mutant ATXN3 expression can indirectly influence APP processing by activating shared enzymatic pathways.",
        "summary": "ATXN3 interacts with APP to modulate convergent proteolytic processing in neurodegeneration, ultimately affecting the accumulation of toxic fragments from both proteins contributes to shared neurodegenerative mechanisms.",
        "evidence": [
          {
            "paper_title": "A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3",
            "journal": "Brain",
            "year": 2017,
            "relevant_quote": "Ataxin-3 (ATXN3), the disease protein in MJD, was shown to be a substrate for mainly two families of proteases: caspases and calpains."
          },
          {
            "paper_title": "Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid β-Protein-Induced Synapse Loss in Alzheimer's Disease",
            "journal": "Cell Reports",
            "year": 2020,
            "relevant_quote": "We hypothesize that one mechanism of Aβ-induced synaptic injury is related to the cleavage of amyloid β precursor protein (APP) at position D664 by caspases that release the putatively cytotoxic C31 peptide."
          },
          {
            "paper_title": "Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment Assessment",
            "journal": "International Journal of Molecular Sciences",
            "year": 2024,
            "relevant_quote": "Moreover, in patients with SCA3, β-amyloid protein at amino acid 42 (Aβ42) is different from other neurological disorders, indicating that this may be useful for differentiating between SCA3 and cognitive and movement disorders. Perhaps they share common pathophysiological pathways that could be included in clinical trials."
          }
        ],
        "pathways": [
          {
            "name": "Amyloid Fibril Formation",
            "canonical_name": "Amyloid Fibril Formation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --regulates--> APP:"
      },
      {
        "primary": "PNKP",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with and enhances the 3'-phosphatase activity of Polynucleotide kinase 3'-phosphatase (PNKP), a key enzyme in DNA strand break repair.",
        "functions": [
          {
            "function": "DNA Strand Break Repair",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly interacts with Polynucleotide kinase 3'-phosphatase (PNKP), a crucial enzyme in the DNA damage response. PNKP processes damaged DNA termini by removing 3'-phosphate groups (3'-phosphatase activity) and adding 5'-phosphate groups (5'-kinase activity), creating suitable ends for DNA polymerases and ligases to complete single- and double-strand break repair.",
            "effect_description": "Wild-type ATXN3 acts as a positive regulator of PNKP, specifically stimulating its 3'-phosphatase activity to promote efficient DNA repair and maintain genomic integrity. In contrast, polyglutamine-expanded mutant ATXN3 also binds to PNKP but inhibits its enzymatic function. This loss of PNKP activity leads to the accumulation of unrepaired DNA strand breaks, chronic activation of the DNA damage response, and ultimately, apoptosis.",
            "biological_consequence": [
              "A DNA strand break with a 3'-phosphate terminus occurs → Wild-type ATXN3 binds to PNKP → The 3'-phosphatase activity of PNKP is stimulated → PNKP removes the 3'-phosphate group, generating a 3'-hydroxyl terminus → The processed DNA end is now a substrate for DNA polymerase and ligase → DNA repair is successfully completed, ensuring neuronal survival."
            ],
            "specific_effects": [
              "Wild-type ATXN3 robustly stimulates the 3'-phosphatase activity of PNKP.",
              "Mutant (polyQ-expanded) ATXN3 interacts with and inactivates PNKP, diminishing its 3'-phosphatase activity.",
              "Inhibition of PNKP by mutant ATXN3 leads to accumulation of DNA damage and chronic activation of the ATM signaling pathway, triggering p53-dependent apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3",
                "journal": "PLoS Genetics",
                "year": 2015,
                "relevant_quote": "In the present study, we show that the essential DNA strand break repair enzyme PNKP (polynucleotide kinase 3'-phosphatase) interacts with, and is inactivated by, the mutant ATXN3, resulting in inefficient DNA repair, persistent accumulation of DNA damage/strand breaks, and subsequent chronic activation of the DNA damage-response ataxia telangiectasia-mutated (ATM) signaling pathway in SCA3.",
                "pmid": "25590633"
              },
              {
                "paper_title": "Ataxin-3, DNA Damage Repair, and SCA3 Cerebellar Degeneration: On the Path to Parsimony?",
                "journal": "PLoS Genetics",
                "year": 2015,
                "relevant_quote": "Chatterjee et al. show that ataxin-3 is a robust interactor with PNKP and promotes PNKP’s phosphatase and DNA repair activities (Fig 1). Importantly, expression of mutant ataxin-3 leads to decreased phosphatase activity in vitro and in the brains of SCA3 transgenic mice.",
                "pmid": "25633989"
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "journal": "Expert Reviews in Molecular Medicine",
                "year": 2024,
                "relevant_quote": "ATXN3 helps DNA repair by interacting with PNKP and stimulating DNA 3′-end-processing activity, thereby preventing the accumulation of DNA SBs (Fig. 3A). Indeed, ATXN3-deficient cells shown decreased PNKP activity accompanied by an increase in DNA SBs.",
                "pmid": "39320846"
              }
            ],
            "pathway": {
              "name": "DNA Damage Response",
              "canonical_name": "DNA Damage Response",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "25590633",
              "25633989",
              "39320846"
            ],
            "interaction_effect": "positive",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 directly interacts with Polynucleotide kinase 3'-phosphatase (PNKP), a crucial enzyme in the DNA damage response. PNKP processes damaged DNA termini by removing 3'-phosphate groups (3'-phosphatase activity) and adding 5'-phosphate groups (5'-kinase activity), creating suitable ends for DNA polymerases and ligases to complete single- and double-strand break repair.",
        "effect": "Wild-type ATXN3 acts as a positive regulator of PNKP, specifically stimulating its 3'-phosphatase activity to promote efficient DNA repair and maintain genomic integrity. In contrast, polyglutamine-expanded mutant ATXN3 also binds to PNKP but inhibits its enzymatic function. This loss of PNKP activity leads to the accumulation of unrepaired DNA strand breaks, chronic activation of the DNA damage response, and ultimately, apoptosis.",
        "summary": "ATXN3 interacts with PNKP to modulate regulation of dna strand break repair, ultimately affecting dna repair is successfully completed, ensuring neuronal survival.",
        "evidence": [
          {
            "paper_title": "Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3",
            "journal": "PLoS Genetics",
            "year": 2015,
            "relevant_quote": "In the present study, we show that the essential DNA strand break repair enzyme PNKP (polynucleotide kinase 3'-phosphatase) interacts with, and is inactivated by, the mutant ATXN3, resulting in inefficient DNA repair, persistent accumulation of DNA damage/strand breaks, and subsequent chronic activation of the DNA damage-response ataxia telangiectasia-mutated (ATM) signaling pathway in SCA3."
          },
          {
            "paper_title": "Ataxin-3, DNA Damage Repair, and SCA3 Cerebellar Degeneration: On the Path to Parsimony?",
            "journal": "PLoS Genetics",
            "year": 2015,
            "relevant_quote": "Chatterjee et al. show that ataxin-3 is a robust interactor with PNKP and promotes PNKP’s phosphatase and DNA repair activities (Fig 1). Importantly, expression of mutant ataxin-3 leads to decreased phosphatase activity in vitro and in the brains of SCA3 transgenic mice."
          },
          {
            "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
            "journal": "Expert Reviews in Molecular Medicine",
            "year": 2024,
            "relevant_quote": "ATXN3 helps DNA repair by interacting with PNKP and stimulating DNA 3′-end-processing activity, thereby preventing the accumulation of DNA SBs (Fig. 3A). Indeed, ATXN3-deficient cells shown decreased PNKP activity accompanied by an increase in DNA SBs."
          }
        ],
        "pathways": [
          {
            "name": "DNA Damage Response",
            "canonical_name": "DNA Damage Response",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "positive",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --activates--> PNKP:"
      },
      {
        "primary": "MDC1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 antagonizes the RNF4-induced polyubiquitination of Mediator of DNA damage checkpoint 1 (MDC1), prolonging its residence time on chromatin to ensure proper DNA damage response activation.",
        "functions": [
          {
            "function": "DNA Damage Signaling",
            "arrow": "activates",
            "cellular_process": "In the DNA damage response (DDR), ATXN3 is recruited to sites of double-strand breaks (DSBs) in a SUMOylation-dependent manner. It directly counteracts the activity of the SUMO-targeted ubiquitin E3 ligase RNF4 on the checkpoint mediator protein MDC1.",
            "effect_description": "ATXN3 deubiquitinates MDC1, which has been targeted for removal from chromatin by RNF4-mediated ubiquitination. This action by ATXN3 prevents the premature removal of MDC1 from the damage site, thereby prolonging its chromatin residence time. This stabilization of MDC1 at the DSB is crucial for a sustained and robust signal, ensuring the efficient recruitment of downstream repair factors like RNF8, RNF168, 53BP1, and BRCA1.",
            "biological_consequence": [
              "DNA double-strand break → MDC1 is recruited to chromatin and SUMOylated → RNF4 ubiquitinates SUMOylated MDC1 for removal → ATXN3 is recruited to DSBs and deubiquitinates MDC1 → MDC1 retention on chromatin is prolonged → Downstream signaling and recruitment of repair factors (RNF8, 53BP1, BRCA1) is consolidated → DNA repair is promoted."
            ],
            "specific_effects": [
              "Directly counteracts RNF4-mediated ubiquitination of MDC1.",
              "Increases the chromatin dwell time of MDC1 at double-strand breaks.",
              "Consolidates robust MDC1-dependent signaling and subsequent DNA repair.",
              "Promotes the recruitment of downstream DNA damage response factors, including RNF8, RNF168, 53BP1, and BRCA1."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4",
                "journal": "The EMBO Journal",
                "year": 2017,
                "relevant_quote": "We find that ataxin-3 negatively regulates ubiquitylation of the checkpoint mediator MDC1, a known RNF4 substrate. Loss of ataxin-3 markedly decreases the chromatin dwell time of MDC1 at DSBs, which can be fully reversed by co-depletion of RNF4.",
                "pmid": "28275011"
              }
            ],
            "pathway": {
              "name": "DNA Damage Response",
              "canonical_name": "DNA Damage Response",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "28275011"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "In the DNA damage response (DDR), ATXN3 is recruited to sites of double-strand breaks (DSBs) in a SUMOylation-dependent manner. It directly counteracts the activity of the SUMO-targeted ubiquitin E3 ligase RNF4 on the checkpoint mediator protein MDC1.",
        "effect": "ATXN3 deubiquitinates MDC1, which has been targeted for removal from chromatin by RNF4-mediated ubiquitination. This action by ATXN3 prevents the premature removal of MDC1 from the damage site, thereby prolonging its chromatin residence time. This stabilization of MDC1 at the DSB is crucial for a sustained and robust signal, ensuring the efficient recruitment of downstream repair factors like RNF8, RNF168, 53BP1, and BRCA1.",
        "summary": "ATXN3 activates MDC1 to modulate dna damage signaling, ultimately affecting dna repair is promoted.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4",
            "journal": "The EMBO Journal",
            "year": 2017,
            "relevant_quote": "We find that ataxin-3 negatively regulates ubiquitylation of the checkpoint mediator MDC1, a known RNF4 substrate. Loss of ataxin-3 markedly decreases the chromatin dwell time of MDC1 at DSBs, which can be fully reversed by co-depletion of RNF4."
          }
        ],
        "pathways": [
          {
            "name": "DNA Damage Response",
            "canonical_name": "DNA Damage Response",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "activation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --activates--> MDC1:"
      },
      {
        "primary": "CHK1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with and deubiquitinates Checkpoint kinase 1 (CHK1), protecting it from degradation and thereby facilitating DNA damage checkpoints and repair.",
        "functions": [
          {
            "function": "DNA Damage Checkpoint",
            "arrow": "activates",
            "cellular_process": "ATXN3 plays a critical role in maintaining genome integrity by regulating the stability of the checkpoint kinase 1 (CHK1), a key effector in the DNA damage response that controls cell cycle progression.",
            "effect_description": "ATXN3 acts as a deubiquitinase for CHK1, directly interacting with it and removing polyubiquitin chains. This protects CHK1 from proteasomal degradation mediated by E3 ligase complexes such as DDB1/CUL4A and FBXO6/CUL1. By stabilizing CHK1, ATXN3 ensures its steady-state levels are maintained, which is essential for a robust G2/M checkpoint arrest in response to DNA damage or replication stress, allowing time for DNA repair.",
            "biological_consequence": [
              "DNA damage or replication stress → ATXN3 interacts with and deubiquitinates CHK1 → CHK1 is protected from DDB1/CUL4A- and FBXO6/CUL1-mediated degradation → CHK1 protein half-life is prolonged and its steady-state level is maintained → Robust G2/M checkpoint is enforced → Cell cycle is arrested to facilitate DNA repair."
            ],
            "specific_effects": [
              "Directly deubiquitinates CHK1, protecting it from proteasomal degradation.",
              "Antagonizes polyubiquitination of CHK1 mediated by DDB1/CUL4A and FBXO6/CUL1 E3 ligase complexes.",
              "Prolongs the half-life of the CHK1 protein.",
              "Maintains steady-state levels of CHK1, which is essential for G2/M checkpoint signaling."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 promotes genome integrity by stabilizing Chk1",
                "journal": "Nucleic Acids Research",
                "year": 2017,
                "relevant_quote": "Under un- perturbed conditions and upon DNA damage, ataxin- 3 (ATX3) interacts with Chk1 and protects it from DDB1/CUL4A- and FBXO6/CUL1-mediated polyu- biquitination and subsequent degradation, thereby promoting DNA repair and checkpoint signaling.",
                "pmid": "28180282"
              }
            ],
            "pathway": {
              "name": "DNA Damage Response",
              "canonical_name": "DNA Damage Response",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "28180282"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 plays a critical role in maintaining genome integrity by regulating the stability of the checkpoint kinase 1 (CHK1), a key effector in the DNA damage response that controls cell cycle progression.",
        "effect": "ATXN3 acts as a deubiquitinase for CHK1, directly interacting with it and removing polyubiquitin chains. This protects CHK1 from proteasomal degradation mediated by E3 ligase complexes such as DDB1/CUL4A and FBXO6/CUL1. By stabilizing CHK1, ATXN3 ensures its steady-state levels are maintained, which is essential for a robust G2/M checkpoint arrest in response to DNA damage or replication stress, allowing time for DNA repair.",
        "summary": "ATXN3 activates CHK1 to modulate dna damage checkpoint, ultimately affecting cell cycle is arrested to facilitate dna repair.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 promotes genome integrity by stabilizing Chk1",
            "journal": "Nucleic Acids Research",
            "year": 2017,
            "relevant_quote": "Under un- perturbed conditions and upon DNA damage, ataxin- 3 (ATX3) interacts with Chk1 and protects it from DDB1/CUL4A- and FBXO6/CUL1-mediated polyu- biquitination and subsequent degradation, thereby promoting DNA repair and checkpoint signaling."
          }
        ],
        "pathways": [
          {
            "name": "DNA Damage Response",
            "canonical_name": "DNA Damage Response",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "activation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --activates--> CHK1:"
      },
      {
        "primary": "RNF4",
        "interaction_type": "indirect",
        "upstream_interactor": "MDC1",
        "mediator_chain": [
          "MDC1"
        ],
        "depth": 2,
        "support_summary": "ATXN3 functionally opposes the E3 ubiquitin ligase RNF4 by deubiquitinating RNF4's substrate, MDC1, indicating an indirect, antagonistic relationship in the DNA damage response pathway.",
        "functions": [
          {
            "function": "MDC1 Ubiquitination",
            "arrow": "inhibits",
            "cellular_process": "In the DNA damage response, the SUMO-targeted ubiquitin ligase (STUbL) RNF4 and the deubiquitinase ATXN3 have opposing roles in regulating the chromatin association of the mediator protein MDC1.",
            "effect_description": "RNF4 ubiquitinates SUMOylated MDC1 at sites of DNA double-strand breaks, which facilitates MDC1's removal from chromatin. ATXN3 is recruited to these same sites and counteracts RNF4's action by deubiquitinating MDC1. This functional opposition by ATXN3 prevents the timely removal of MDC1, thereby prolonging its residence time at the damage site and ensuring a sustained downstream signaling cascade for DNA repair.",
            "biological_consequence": [
              "DNA double-strand break → MDC1 is SUMOylated and recruited to chromatin → RNF4 ubiquitinates MDC1 to promote its removal → ATXN3 deubiquitinates MDC1 → RNF4's action is antagonized, and MDC1 is retained at chromatin → DNA damage signaling is prolonged and consolidated."
            ],
            "specific_effects": [
              "Functionally antagonizes the ubiquitin ligase activity of RNF4 towards MDC1.",
              "Negatively regulates RNF4-dependent removal of MDC1 from chromatin at sites of DNA damage.",
              "The opposing activities of ATXN3 and RNF4 create a balanced regulatory system for MDC1-dependent signaling."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4",
                "journal": "The EMBO Journal",
                "year": 2017,
                "relevant_quote": "Here, we report that the deubiquitylation enzyme (DUB) ataxin-3 counteracts RNF4 activity during the DNA double-strand break (DSB) response. We find that ataxin-3 negatively regulates ubiquitylation of the checkpoint mediator MDC1, a known RNF4 substrate.",
                "pmid": "28275011"
              }
            ],
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "28275011"
            ],
            "direct_arrow": "activates",
            "interaction_effect": "inhibition",
            "interaction_direction": "main_to_primary",
            "function_effect": "inhibition",
            "arrow_context": {
              "direct_from": "MDC1",
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "inhibits",
              "mediator_chain": [
                "MDC1"
              ],
              "is_indirect": true
            },
            "net_arrow": "inhibits",
            "net_effect": "inhibition",
            "direct_effect": "activation"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The interaction is indirect and antagonistic. ATXN3 does not directly regulate RNF4 itself, but rather opposes its function by acting on a common substrate, MDC1.",
        "mechanism": "In the DNA damage response, the SUMO-targeted ubiquitin ligase (STUbL) RNF4 and the deubiquitinase ATXN3 have opposing roles in regulating the chromatin association of the mediator protein MDC1.",
        "effect": "RNF4 ubiquitinates SUMOylated MDC1 at sites of DNA double-strand breaks, which facilitates MDC1's removal from chromatin. ATXN3 is recruited to these same sites and counteracts RNF4's action by deubiquitinating MDC1. This functional opposition by ATXN3 prevents the timely removal of MDC1, thereby prolonging its residence time at the damage site and ensuring a sustained downstream signaling cascade for DNA repair.",
        "summary": "ATXN3 inhibits RNF4 to modulate mdc1 ubiquitination, ultimately affecting dna damage signaling is prolonged and consolidated.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4",
            "journal": "The EMBO Journal",
            "year": 2017,
            "relevant_quote": "Here, we report that the deubiquitylation enzyme (DUB) ataxin-3 counteracts RNF4 activity during the DNA double-strand break (DSB) response. We find that ataxin-3 negatively regulates ubiquitylation of the checkpoint mediator MDC1, a known RNF4 substrate."
          }
        ],
        "pathways": [
          {
            "name": "Ubiquitin-Proteasome System",
            "canonical_name": "Proteasomal Degradation",
            "ontology_id": "GO:0010498",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "MDC1 --inhibits--> RNF4:"
      },
      {
        "primary": "RNF8",
        "interaction_type": "indirect",
        "upstream_interactor": "VCP",
        "mediator_chain": [
          "VCP"
        ],
        "depth": 2,
        "support_summary": "The ATXN3-VCP/p97 complex promotes the extraction of the E3 ubiquitin ligase RNF8 from sites of DNA damage to prevent its overaccumulation and ensure proper double-strand break repair.",
        "functions": [
          {
            "function": "RNF8 Chromatin Extraction",
            "arrow": "activates",
            "cellular_process": "The ATXN3-VCP/p97 complex regulates the homeostasis of the E3 ubiquitin ligase RNF8, a key factor in DNA repair, at sites of genotoxic stress.",
            "effect_description": "During the DNA damage response, the ATXN3-VCP complex facilitates the extraction of RNF8 from chromatin. This prevents the hyper-accumulation of RNF8 at DNA lesions, which is crucial for balancing DNA repair pathway choice and promoting cell survival.",
            "biological_consequence": [
              "DNA damage → RNF8 accumulates on chromatin → ATXN3-VCP complex extracts RNF8 → RNF8 levels are balanced → DNA repair pathway choice is regulated → Cell survival is promoted"
            ],
            "specific_effects": [
              "Stimulates the extraction of RNF8 from chromatin at sites of DNA lesions.",
              "Suppresses overaccumulation of RNF8 at sites of DNA damage.",
              "Deubiquitinates soluble RNF8 to protect it from premature degradation."
            ],
            "evidence": [
              {
                "paper_title": "The p97–Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8",
                "year": 2019,
                "pmid": "31613024"
              },
              {
                "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
                "year": 2023,
                "pmid": "36971114"
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": null,
              "chain": [
                "VCP"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "DNA Damage Response",
              "canonical_name": "DNA Damage Response",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "31613024",
              "36971114"
            ],
            "direct_arrow": "activates",
            "function_effect": "activation",
            "arrow_context": {
              "direct_from": "VCP",
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "activates",
              "mediator_chain": [
                "VCP"
              ],
              "is_indirect": true
            },
            "net_arrow": "activates",
            "net_effect": "activation",
            "direct_effect": "activation"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "mechanism": "The ATXN3-VCP/p97 complex regulates the homeostasis of the E3 ubiquitin ligase RNF8, a key factor in DNA repair, at sites of genotoxic stress.",
        "effect": "During the DNA damage response, the ATXN3-VCP complex facilitates the extraction of RNF8 from chromatin. This prevents the hyper-accumulation of RNF8 at DNA lesions, which is crucial for balancing DNA repair pathway choice and promoting cell survival.",
        "summary": "ATXN3 activates RNF8 to modulate rnf8 chromatin extraction, ultimately affecting cell survival is promoted.",
        "evidence": [
          {
            "paper_title": "The p97–Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8",
            "year": 2019
          },
          {
            "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
            "year": 2023
          }
        ],
        "pathways": [
          {
            "name": "DNA Damage Response",
            "canonical_name": "DNA Damage Response",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "activation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "VCP --activates--> RNF8:"
      },
      {
        "primary": "PML",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the Promyelocytic leukemia protein (PML) and co-localizes within PML nuclear bodies, which are involved in transcriptional regulation and stress responses.",
        "functions": [
          {
            "function": "Stress Response",
            "arrow": "activates",
            "cellular_process": "ATXN3 co-localizes with the Promyelocytic leukemia protein (PML) within PML nuclear bodies, which are dynamic sub-nuclear structures that act as hubs for various cellular processes.",
            "effect_description": "Through its interaction with PML, ATXN3 is positioned to participate in the functions of PML nuclear bodies, including the regulation of transcriptional responses, protein post-translational modification (like SUMOylation), and the cellular response to stress.",
            "biological_consequence": [
              "Cellular stress → ATXN3 co-localizes with PML in nuclear bodies → Regulation of stress-responsive genes and proteins → Cellular homeostasis is maintained"
            ],
            "specific_effects": [
              "Co-localizes within PML nuclear bodies."
            ],
            "evidence": [
              {
                "paper_title": "Sumoylation of MDC1 is important for proper DNA damage response",
                "year": 2012,
                "pmid": "22635276"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "primary_to_main",
            "pathway": {
              "name": "Cellular Stress Response",
              "canonical_name": "Cellular Stress Response",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "22635276"
            ],
            "function_effect": "activation"
          },
          {
            "function": "ATXN3 Deubiquitinase Activity",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 is recruited to Promyelocytic leukemia (PML) nuclear bodies through a specific interaction with the PML-II isoform.",
            "effect_description": "The specific PML-II isoform binds to ATXN3 and negatively regulates its enzymatic function, inhibiting its deubiquitinase activity. This suggests that PML-NBs act as sites where ATXN3 function is modulated.",
            "biological_consequence": [
              "ATXN3 is recruited to PML-NBs via PML-II → PML-II binds to ATXN3 → ATXN3 deubiquitinase activity is inhibited → The stability of ATXN3 substrates within the PML-NB is altered"
            ],
            "specific_effects": [
              "Specifically binds to the C-terminal region of the PML-II isoform.",
              "Co-localizes with PML-II in PML nuclear bodies.",
              "PML-II binding inhibits the ubiquitin hydrolase activity of ATXN3."
            ],
            "evidence": [
              {
                "paper_title": "PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity",
                "year": 2021,
                "pmid": "33798946"
              },
              {
                "paper_title": "SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97",
                "year": 2015,
                "pmid": "26073430"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "primary_to_main",
            "pathway": {
              "name": "Ubiquitin-Proteasome System",
              "canonical_name": "Proteasomal Degradation",
              "ontology_id": "GO:0010498",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "33798946",
              "26073430"
            ],
            "function_effect": "inhibition"
          }
        ],
        "arrow": "inhibits",
        "direction": "primary_to_main",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates",
            "inhibits"
          ]
        },
        "mechanism": "ATXN3 co-localizes with the Promyelocytic leukemia protein (PML) within PML nuclear bodies, which are dynamic sub-nuclear structures that act as hubs for various cellular processes. ATXN3 is recruited to Promyelocytic leukemia (PML) nuclear bodies through a specific interaction with the PML-II isoform.",
        "effect": "Through its interaction with PML, ATXN3 is positioned to participate in the functions of PML nuclear bodies, including the regulation of transcriptional responses, protein post-translational modification (like SUMOylation), and the cellular response to stress.; The specific PML-II isoform binds to ATXN3 and negatively regulates its enzymatic function, inhibiting its deubiquitinase activity. This suggests that PML-NBs act as sites where ATXN3 function is modulated.",
        "summary": "ATXN3 regulates PML to regulate stress response and atxn3 deubiquitinase activity, ultimately affecting cellular homeostasis is maintained.",
        "evidence": [
          {
            "paper_title": "Sumoylation of MDC1 is important for proper DNA damage response",
            "year": 2012
          },
          {
            "paper_title": "PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity",
            "year": 2021
          },
          {
            "paper_title": "SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97",
            "year": 2015
          }
        ],
        "pathways": [
          {
            "name": "Ubiquitin-Proteasome System",
            "canonical_name": "Proteasomal Degradation",
            "ontology_id": "GO:0010498",
            "ontology_source": "GO",
            "confidence": 0.8
          },
          {
            "name": "Cellular Stress Response",
            "canonical_name": "Cellular Stress Response",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 4
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--inhibits-- PML:"
      },
      {
        "primary": "HSP70",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "As a chaperone-associated deubiquitinase, ATXN3 interacts with Heat shock protein 70 (HSP70) in the context of cellular protein quality control and folding.",
        "functions": [
          {
            "function": "Substrate Triage for Degradation or Refolding",
            "arrow": "activates",
            "cellular_process": "ATXN3 collaborates with the molecular chaperone HSP70 and the E3 ligase STUB1/CHIP in a key protein quality control checkpoint.",
            "effect_description": "HSP70 recognizes and binds misfolded proteins, presenting them to the STUB1/CHIP ligase for ubiquitination. ATXN3 is then recruited to this complex where it can edit or remove the ubiquitin chains, acting as a molecular switch. Trimming the chains can delay degradation and provide a window for refolding, while complete removal rescues the substrate.",
            "biological_consequence": [
              "Misfolded protein → HSP70/STUB1 complex binds and ubiquitinates → ATXN3 edits ubiquitin chain → Substrate fate is determined (refolding vs. degradation) → Proteostasis is maintained"
            ],
            "specific_effects": [
              "Forms a triage complex with HSP70 and STUB1/CHIP.",
              "Edits ubiquitin chains on chaperone-bound substrates to influence their fate.",
              "HSP70 acts as a switch controlling the interaction between CHIP and its substrates."
            ],
            "evidence": [
              {
                "paper_title": "The E3 Ubiquitin Ligase CHIP and the Molecular Chaperone Hsc70 Form a Dynamic, Tethered Complex",
                "year": 2014,
                "pmid": "23865999"
              },
              {
                "paper_title": "Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation",
                "year": 2021,
                "pmid": "33619536"
              },
              {
                "paper_title": "Basal and stress-induced Hsp70 are modulated by ataxin-3",
                "year": null,
                "pmid": "22777893"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "Chaperone-Mediated Protein Folding",
              "canonical_name": "Protein Folding",
              "ontology_id": "GO:0006457",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "23865999",
              "33619536",
              "22777893"
            ],
            "function_effect": "activation"
          }
        ],
        "arrow": "regulates",
        "direction": "bidirectional",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "mechanism": "ATXN3 collaborates with the molecular chaperone HSP70 and the E3 ligase STUB1/CHIP in a key protein quality control checkpoint.",
        "effect": "HSP70 recognizes and binds misfolded proteins, presenting them to the STUB1/CHIP ligase for ubiquitination. ATXN3 is then recruited to this complex where it can edit or remove the ubiquitin chains, acting as a molecular switch. Trimming the chains can delay degradation and provide a window for refolding, while complete removal rescues the substrate.",
        "summary": "ATXN3 activates HSP70 to modulate substrate triage for degradation or refolding, ultimately affecting proteostasis is maintained.",
        "evidence": [
          {
            "paper_title": "The E3 Ubiquitin Ligase CHIP and the Molecular Chaperone Hsc70 Form a Dynamic, Tethered Complex",
            "year": 2014
          },
          {
            "paper_title": "Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation",
            "year": 2021
          },
          {
            "paper_title": "Basal and stress-induced Hsp70 are modulated by ataxin-3",
            "year": null
          }
        ],
        "pathways": [
          {
            "name": "Chaperone-Mediated Protein Folding",
            "canonical_name": "Protein Folding",
            "ontology_id": "GO:0006457",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--regulates--> HSP70:"
      },
      {
        "primary": "TRAF6",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with and deubiquitinates TNF receptor-associated factor 6 (TRAF6), a key E3 ligase in inflammatory signaling pathways like NF-κB.",
        "functions": [
          {
            "function": "NF-κB Signaling Pathway",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 acts as a deubiquitinase for TNF receptor-associated factor 6 (TRAF6), a key E3 ligase that synthesizes K63-linked polyubiquitin chains to activate downstream inflammatory signaling.",
            "effect_description": "By cleaving the K63-linked ubiquitin chains from TRAF6, ATXN3 counteracts its E3 ligase activity. This prevents the recruitment and activation of downstream kinases like TAK1, thereby suppressing the activation of the NF-κB transcription factor and reducing inflammatory gene expression.",
            "biological_consequence": [
              "Inflammatory signal → TRAF6 is activated and auto-ubiquitinated (K63) → ATXN3 deubiquitinates TRAF6 → Downstream kinase activation is blocked → NF-κB remains inactive in the cytoplasm → Inflammatory response is dampened"
            ],
            "specific_effects": [
              "Removes K63-linked polyubiquitin chains from TRAF6.",
              "Suppresses the activation of the NF-κB pathway."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024,
                "pmid": "38497605"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "NF-κB Signaling Pathway",
              "canonical_name": "NF-kB Signaling",
              "ontology_id": "hsa04064",
              "ontology_source": "KEGG",
              "confidence": 0.8
            },
            "pmids": [
              "38497605"
            ]
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "_validation_status": "rejected",
        "mechanism": "ATXN3 acts as a deubiquitinase for TNF receptor-associated factor 6 (TRAF6), a key E3 ligase that synthesizes K63-linked polyubiquitin chains to activate downstream inflammatory signaling.",
        "effect": "By cleaving the K63-linked ubiquitin chains from TRAF6, ATXN3 counteracts its E3 ligase activity. This prevents the recruitment and activation of downstream kinases like TAK1, thereby suppressing the activation of the NF-κB transcription factor and reducing inflammatory gene expression.",
        "summary": "ATXN3 inhibits TRAF6 to modulate nf-κb signaling pathway, ultimately affecting inflammatory response is dampened.",
        "evidence": [
          {
            "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
            "year": 2024
          }
        ],
        "pathways": [
          {
            "name": "NF-κB Signaling Pathway",
            "canonical_name": "NF-kB Signaling",
            "ontology_id": "hsa04064",
            "ontology_source": "KEGG",
            "confidence": 0.8
          }
        ],
        "arrow_notation": "ATXN3 --inhibits--> TRAF6:"
      },
      {
        "primary": "RHEB",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 acts as a negative regulator of mTORC1 signaling by directly deubiquitinating Ras homolog enriched in brain (RHEB), which promotes its inactivation.",
        "functions": [
          {
            "function": "mTORC1 Signaling",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 is a deubiquitinase for the small GTPase Ras homolog enriched in brain (RHEB). Polyubiquitination of RHEB on the lysosomal surface enhances its binding affinity for the mTORC1 complex, a master regulator of cell growth.",
            "effect_description": "Under amino acid-starved conditions, ATXN3 is recruited to the lysosome where it removes polyubiquitin chains from RHEB. This deubiquitination reduces RHEB's ability to bind and activate mTORC1, thus suppressing its kinase activity. When amino acids are present, the Rag GTPases become active and block the lysosomal localization of ATXN3, allowing RHEB to remain polyubiquitinated and fully activate mTORC1.",
            "biological_consequence": [
              "Amino acid starvation → Inactive Rag GTPases recruit ATXN3 to the lysosome → ATXN3 deubiquitinates lysosomal RHEB → The binding affinity of RHEB for mTORC1 is reduced → mTORC1 kinase activity is suppressed → Cellular anabolic processes (e.g., protein synthesis) are inhibited."
            ],
            "specific_effects": [
              "Removes polyubiquitin chains from RHEB.",
              "Reduces the binding interaction between RHEB and mTORC1.",
              "Functions as a negative regulator of mTORC1 signaling in the absence of amino acids."
            ],
            "evidence": [
              {
                "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
                "journal": "Molecular Cell",
                "year": 2020,
                "relevant_quote": "We report that amino acids enhance the polyubiquitination of Rheb (Ub-Rheb), which shows a strong binding preference for mTORC1 and supports its activation... Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation.",
                "pmid": "33157014"
              }
            ],
            "pathway": {
              "name": "mTOR Signaling Pathway",
              "canonical_name": "mTOR Signaling",
              "ontology_id": "hsa04150",
              "ontology_source": "KEGG",
              "confidence": 0.8
            },
            "pmids": [
              "33157014"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "main_to_primary",
            "function_effect": "inhibition"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 is a deubiquitinase for the small GTPase Ras homolog enriched in brain (RHEB). Polyubiquitination of RHEB on the lysosomal surface enhances its binding affinity for the mTORC1 complex, a master regulator of cell growth.",
        "effect": "Under amino acid-starved conditions, ATXN3 is recruited to the lysosome where it removes polyubiquitin chains from RHEB. This deubiquitination reduces RHEB's ability to bind and activate mTORC1, thus suppressing its kinase activity. When amino acids are present, the Rag GTPases become active and block the lysosomal localization of ATXN3, allowing RHEB to remain polyubiquitinated and fully activate mTORC1.",
        "summary": "ATXN3 inhibits RHEB to modulate mtorc1 signaling, ultimately affecting cellular anabolic processes (e.g., protein synthesis) are inhibited.",
        "evidence": [
          {
            "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
            "journal": "Molecular Cell",
            "year": 2020,
            "relevant_quote": "We report that amino acids enhance the polyubiquitination of Rheb (Ub-Rheb), which shows a strong binding preference for mTORC1 and supports its activation... Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation."
          }
        ],
        "pathways": [
          {
            "name": "mTOR Signaling Pathway",
            "canonical_name": "mTOR Signaling",
            "ontology_id": "hsa04150",
            "ontology_source": "KEGG",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --inhibits--> RHEB:"
      },
      {
        "primary": "TBP",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is known to cooperate with the general transcription factor TATA-box binding protein (TBP) as part of its role in regulating gene expression.",
        "functions": [
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "Wild-type ATXN3 acts as a transcriptional co-repressor. While it interacts with general transcription factors like TBP, its functional role is to inhibit gene expression.",
            "effect_description": "ATXN3 binds to specific DNA regions in gene promoters and recruits corepressor complexes containing histone deacetylase 3 (HDAC3) and the nuclear receptor corepressor (NCoR). This recruitment leads to the deacetylation of local histones, resulting in a more compact chromatin structure that is inaccessible to the transcription machinery, thereby repressing gene expression.",
            "biological_consequence": [
              "ATXN3 binds to a target gene promoter → ATXN3 recruits a corepressor complex including HDAC3 and NCoR → HDAC3 deacetylates histones (e.g., H3) at the promoter region → Chromatin becomes condensed → Access by RNA Polymerase II and general transcription factors (including TBP) is blocked → Transcription of the target gene is repressed."
            ],
            "specific_effects": [
              "Functions as a transcriptional co-repressor.",
              "Recruits HDAC3 and NCoR to gene promoters.",
              "Promotes histone deacetylation at target promoters.",
              "Inhibits transcription of target genes like MMP-2."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "journal": "The Journal of Neuroscience",
                "year": 2006,
                "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter.",
                "pmid": "17079677"
              },
              {
                "paper_title": "Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities",
                "journal": "The Journal of Biological Chemistry",
                "year": 2002,
                "relevant_quote": "In the present study we use cell transfections, in vitro binding, co-immunoprecipitations, and reporter assays to show that the polyglutamine disease protein, ataxin-3, interacts with the major histone acetyltransferases cAMP-response-element binding protein (CREB)-binding protein, p300, and p300/CREB-binding protein-associated factor and inhibits transcription by these coactivators.",
                "pmid": "12297501"
              }
            ],
            "pathway": {
              "name": "Transcriptional Regulation",
              "canonical_name": "Transcription",
              "ontology_id": "GO:0006351",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "17079677",
              "12297501"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "activates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "activates",
            "direct_arrow": "activates",
            "net_effect": "activation",
            "direct_effect": "activation"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "MECHANISTIC OPPOSITE DETECTED. The input claim that ATXN3 *activates* basal transcription in cooperation with TBP is incorrect. Primary literature establishes that wild-type ATXN3 functions as a transcriptional *co-repressor*. It does not activate, but rather inhibits transcription of target genes by interacting with histone deacetylase (HDAC) complexes.",
        "mechanism": "Wild-type ATXN3 acts as a transcriptional co-repressor. While it interacts with general transcription factors like TBP, its functional role is to inhibit gene expression.",
        "effect": "ATXN3 binds to specific DNA regions in gene promoters and recruits corepressor complexes containing histone deacetylase 3 (HDAC3) and the nuclear receptor corepressor (NCoR). This recruitment leads to the deacetylation of local histones, resulting in a more compact chromatin structure that is inaccessible to the transcription machinery, thereby repressing gene expression.",
        "summary": "ATXN3 inhibits TBP to modulate transcriptional repression, ultimately affecting transcription of the target gene is repressed.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
            "journal": "The Journal of Neuroscience",
            "year": 2006,
            "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
          },
          {
            "paper_title": "Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities",
            "journal": "The Journal of Biological Chemistry",
            "year": 2002,
            "relevant_quote": "In the present study we use cell transfections, in vitro binding, co-immunoprecipitations, and reporter assays to show that the polyglutamine disease protein, ataxin-3, interacts with the major histone acetyltransferases cAMP-response-element binding protein (CREB)-binding protein, p300, and p300/CREB-binding protein-associated factor and inhibits transcription by these coactivators."
          }
        ],
        "pathways": [
          {
            "name": "Transcriptional Regulation",
            "canonical_name": "Transcription",
            "ontology_id": "GO:0006351",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --inhibits--> TBP:"
      },
      {
        "primary": "PCAF",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the histone acetyltransferase p300/CBP-associated factor (PCAF), linking it to the machinery of transcriptional regulation.",
        "functions": [
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "Normal Ataxin-3 (ATXN3) binds to specific DNA sequences within the promoters of target genes, such as the matrix metalloproteinase-2 (MMP-2) gene. At these sites, ATXN3 serves as a scaffold to recruit a transcriptional repressor complex.",
            "effect_description": "ATXN3 recruits the corepressor NCoR and Histone Deacetylase 3 (HDAC3) to the gene promoter. The recruited HDAC3 then catalyzes the removal of acetyl groups from histone tails (e.g., on Histone H3). This deacetylation increases the positive charge of the histones, strengthening their interaction with DNA, which results in a more compact chromatin structure (heterochromatin). This condensed state physically blocks the transcriptional machinery from accessing the gene, thereby repressing its expression.",
            "biological_consequence": [
              "Normal ATXN3 binds to a target gene promoter → ATXN3 recruits the NCoR/HDAC3 co-repressor complex → HDAC3 deacetylates histones at the promoter → Chromatin structure becomes condensed → Access of transcriptional machinery is blocked → Gene transcription is repressed."
            ],
            "specific_effects": [
              "Recruits HDAC3 and NCoR to specific gene promoters.",
              "Promotes deacetylation of histones at target loci.",
              "Induces a localized condensed chromatin state to silence gene expression."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
                "journal": "The Journal of Neuroscience",
                "year": 2006,
                "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter.",
                "pmid": "17079677"
              },
              {
                "paper_title": "Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities",
                "journal": "The Journal of Biological Chemistry",
                "year": 2002,
                "relevant_quote": "The N-terminal domain of ataxin-3 inhibits histone acetylation by p300 in vitro and inhibits transcription in vivo. Histone binding and blocking access of coactivators to acetylation sites on histones appears to be the mechanism of inhibition.",
                "pmid": "12297501"
              }
            ],
            "pathway": {
              "name": "Transcriptional Regulation",
              "canonical_name": "Transcription",
              "ontology_id": "GO:0006351",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "17079677",
              "12297501"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "consequences": [
              "ATXN3 binds to the histone acetyltransferase (HAT) PCAF → ATXN3 inhibits the HAT activity of PCAF → Histone acetylation at target gene promoters is reduced → Chromatin remains in a condensed state → Access of transcriptional machinery is blocked → Gene transcription is repressed."
            ],
            "function_effect": "activation"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input claim that ATXN3 directly inhibits the HAT activity of PCAF is a contextual error. Primary literature demonstrates a different, more specific mechanism for transcriptional repression. Normal ATXN3 acts as a transcriptional repressor by binding to target gene promoters and recruiting a co-repressor complex containing Histone Deacetylase 3 (HDAC3) and Nuclear Receptor Corepressor (NCoR). This complex then removes acetyl groups from histones, leading to a condensed chromatin state and gene silencing. While ATXN3 does interact with HATs like PCAF, its repressive function in this context is executed via histone deacetylation by the recruited HDAC3, not by direct inhibition of PCAF's acetylation activity.",
        "mechanism": "Normal Ataxin-3 (ATXN3) binds to specific DNA sequences within the promoters of target genes, such as the matrix metalloproteinase-2 (MMP-2) gene. At these sites, ATXN3 serves as a scaffold to recruit a transcriptional repressor complex.",
        "effect": "ATXN3 recruits the corepressor NCoR and Histone Deacetylase 3 (HDAC3) to the gene promoter. The recruited HDAC3 then catalyzes the removal of acetyl groups from histone tails (e.g., on Histone H3). This deacetylation increases the positive charge of the histones, strengthening their interaction with DNA, which results in a more compact chromatin structure (heterochromatin). This condensed state physically blocks the transcriptional machinery from accessing the gene, thereby repressing its expression.",
        "summary": "ATXN3 inhibits PCAF to modulate transcriptional repression, ultimately affecting gene transcription is repressed.",
        "evidence": [
          {
            "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
            "journal": "The Journal of Neuroscience",
            "year": 2006,
            "relevant_quote": "Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
          },
          {
            "paper_title": "Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities",
            "journal": "The Journal of Biological Chemistry",
            "year": 2002,
            "relevant_quote": "The N-terminal domain of ataxin-3 inhibits histone acetylation by p300 in vitro and inhibits transcription in vivo. Histone binding and blocking access of coactivators to acetylation sites on histones appears to be the mechanism of inhibition."
          }
        ],
        "pathways": [
          {
            "name": "Transcriptional Regulation",
            "canonical_name": "Transcription",
            "ontology_id": "GO:0006351",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --inhibits--> PCAF:"
      },
      {
        "primary": "FBXL3",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "The F-box protein FBXL3, a component of the SCF ubiquitin ligase complex, binds to ATXN3 and promotes its ubiquitination and subsequent degradation.",
        "functions": [
          {
            "function": "ATXN3 Stability",
            "arrow": "inhibits",
            "cellular_process": "The F-box protein FBXL3 is a substrate recognition component of the SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complex. FBXL3 directly binds to the ATXN3 protein, marking it as a substrate for ubiquitination.",
            "effect_description": "By binding to ATXN3, FBXL3 recruits the rest of the SCF E3 ligase machinery, including CUL1 and SKP1. This complex then catalyzes the attachment of polyubiquitin chains to ATXN3. This polyubiquitination serves as a signal for the proteasome to recognize and degrade the ATXN3 protein, thereby controlling its cellular abundance.",
            "biological_consequence": [
              "FBXL3, as part of the SCF complex, binds to ATXN3 → The SCF-FBXL3 complex polyubiquitinates ATXN3 → Polyubiquitinated ATXN3 is recognized by the 26S proteasome → ATXN3 is degraded → Cellular levels of ATXN3 are reduced."
            ],
            "specific_effects": [
              "Mediates the polyubiquitination of both wild-type and mutant ATXN3.",
              "Reduces the protein half-life of ATXN3 through proteasomal degradation.",
              "Functions in a CUL1-dependent manner."
            ],
            "evidence": [
              {
                "paper_title": "Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia Type 3 disease protein",
                "journal": "PLoS Genetics",
                "year": 2021,
                "relevant_quote": "We overexpressed FBXL3 in SCA3 NPCs and confirmed that high levels of FBXL3 reduce endogenous levels of both wild-type and mutant ATXN3 proteins to 58% and 64%, respectively, of control levels... To evaluate if FBXL3-mediated reduction of ATXN3 abundance occurs via the SCF/CUL1 ubiquitination complex, we co-electroporated plasmid overexpressing FBXL3 while also decreasing CUL1 with siRNAs against CUL1.",
                "pmid": "31783119"
              }
            ],
            "pathway": {
              "name": "Protein Stability Regulation",
              "canonical_name": "Protein Stability Regulation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "31783119"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "primary_to_main",
            "function_effect": "inhibition"
          }
        ],
        "arrow": "inhibits",
        "direction": "primary_to_main",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "The F-box protein FBXL3 is a substrate recognition component of the SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complex. FBXL3 directly binds to the ATXN3 protein, marking it as a substrate for ubiquitination.",
        "effect": "By binding to ATXN3, FBXL3 recruits the rest of the SCF E3 ligase machinery, including CUL1 and SKP1. This complex then catalyzes the attachment of polyubiquitin chains to ATXN3. This polyubiquitination serves as a signal for the proteasome to recognize and degrade the ATXN3 protein, thereby controlling its cellular abundance.",
        "summary": "ATXN3 inhibits FBXL3 to modulate atxn3 stability, ultimately affecting cellular levels of atxn3 are reduced.",
        "evidence": [
          {
            "paper_title": "Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia Type 3 disease protein",
            "journal": "PLoS Genetics",
            "year": 2021,
            "relevant_quote": "We overexpressed FBXL3 in SCA3 NPCs and confirmed that high levels of FBXL3 reduce endogenous levels of both wild-type and mutant ATXN3 proteins to 58% and 64%, respectively, of control levels... To evaluate if FBXL3-mediated reduction of ATXN3 abundance occurs via the SCF/CUL1 ubiquitination complex, we co-electroporated plasmid overexpressing FBXL3 while also decreasing CUL1 with siRNAs against CUL1."
          }
        ],
        "pathways": [
          {
            "name": "Protein Stability Regulation",
            "canonical_name": "Protein Stability Regulation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--inhibits-- FBXL3:"
      },
      {
        "primary": "CAMK2A",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 2,
        "support_summary": "Proteomic analysis of SCA3 models shows that mutant ATXN3 abnormally interacts with subunits of large protein complexes, including Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A).",
        "functions": [
          {
            "function": "Synaptic Plasticity and Dendritic Maintenance",
            "arrow": "inhibits",
            "cellular_process": "In Spinocerebellar Ataxia Type 3 (SCA3), the mutant ATXN3 protein interacts with and sensitizes the type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1), an intracellular calcium release channel located on the endoplasmic reticulum.",
            "effect_description": "The sensitization of InsP3R1 by mutant ATXN3 leads to excessive calcium release from the ER, causing dysregulation of intracellular calcium homeostasis. Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A) is a critical kinase whose activity is tightly regulated by calcium/calmodulin binding. The chronic disruption of calcium signaling impairs the proper activation and function of CAMK2A, which is essential for synaptic plasticity, long-term potentiation, and maintenance of dendritic and synaptic structures. This functional impairment of CAMK2A-dependent pathways contributes to the synaptic loss and neurodegeneration characteristic of SCA3.",
            "biological_consequence": [
              "Mutant ATXN3 expression → Sensitization of IP3R1 Ca2+ channels → Dysregulation of intracellular calcium homeostasis → Impaired activation/function of Ca2+/calmodulin-dependent protein kinase II (CAMK2A) → Reduced synaptic plasticity and mitochondrial transport → Dendritic and synapse loss → Neurodegeneration."
            ],
            "specific_effects": [
              "Mutant ATXN3 physically associates with InsP3R1, increasing its sensitivity to InsP3.",
              "Causes deranged intracellular Ca2+ signaling in neuronal models of SCA3.",
              "Proteomic analysis shows mutant ATXN3 abnormally interacts with CAMK2A in a SCA3 mouse brain."
            ],
            "evidence": [
              {
                "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
                "journal": "Frontiers in Molecular Neuroscience",
                "year": 2023,
                "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b... The top result identified by two different strategies both in cerebellum and cerebral cortex was Calcium/Calmodulin Dependent Protein Kinase II alpha and beta (Camk2a and b), which plays a pivotal role in mitochondrial transport in axons.",
                "pmid": "37033372"
              },
              {
                "paper_title": "Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3",
                "journal": "The Journal of Neuroscience",
                "year": 2008,
                "relevant_quote": "In biochemical experiments, we demonstrate that mutant ATX3exp specifically associated with the type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1), an intracellular calcium (Ca2+) release channel. In electrophysiological and Ca2+ imaging experiments, we show that InsP3R1 was sensitized to activation by InsP3 in the presence of mutant ATX3exp.",
                "pmid": "19036964"
              }
            ],
            "pathway": {
              "name": "Synaptic Plasticity",
              "canonical_name": "Synaptic Plasticity",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "37033372",
              "19036964"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "main_to_primary",
            "function_effect": "inhibition",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "inhibits",
              "net_from": "ATXN3",
              "net_arrow": "inhibits",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "inhibits",
            "direct_arrow": "inhibits",
            "net_effect": "inhibition",
            "direct_effect": "inhibition"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "_chain_inferred": true,
        "is_valid": true,
        "mechanism_correction": "The input claim of an indirect, functional opposition is correct but was based on weak evidence from a related disease (SCA2). The claim is now validated with stronger, SCA3-specific evidence. Recent proteomic studies confirm that mutant ATXN3 abnormally interacts with CAMK2A in an SCA3 mouse model. Furthermore, a clear mechanistic link has been established: mutant ATXN3 dysregulates intracellular calcium signaling by sensitizing the IP3 receptor, a key upstream event that would directly impair the function of a calcium-dependent kinase like CAMK2A.",
        "mechanism": "In Spinocerebellar Ataxia Type 3 (SCA3), the mutant ATXN3 protein interacts with and sensitizes the type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1), an intracellular calcium release channel located on the endoplasmic reticulum.",
        "effect": "The sensitization of InsP3R1 by mutant ATXN3 leads to excessive calcium release from the ER, causing dysregulation of intracellular calcium homeostasis. Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A) is a critical kinase whose activity is tightly regulated by calcium/calmodulin binding. The chronic disruption of calcium signaling impairs the proper activation and function of CAMK2A, which is essential for synaptic plasticity, long-term potentiation, and maintenance of dendritic and synaptic structures. This functional impairment of CAMK2A-dependent pathways contributes to the synaptic loss and neurodegeneration characteristic of SCA3.",
        "summary": "ATXN3 inhibits CAMK2A to modulate synaptic plasticity and dendritic maintenance, ultimately affecting neurodegeneration.",
        "evidence": [
          {
            "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
            "journal": "Frontiers in Molecular Neuroscience",
            "year": 2023,
            "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b... The top result identified by two different strategies both in cerebellum and cerebral cortex was Calcium/Calmodulin Dependent Protein Kinase II alpha and beta (Camk2a and b), which plays a pivotal role in mitochondrial transport in axons."
          },
          {
            "paper_title": "Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3",
            "journal": "The Journal of Neuroscience",
            "year": 2008,
            "relevant_quote": "In biochemical experiments, we demonstrate that mutant ATX3exp specifically associated with the type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1), an intracellular calcium (Ca2+) release channel. In electrophysiological and Ca2+ imaging experiments, we show that InsP3R1 was sensitized to activation by InsP3 in the presence of mutant ATX3exp."
          }
        ],
        "pathways": [
          {
            "name": "Synaptic Plasticity",
            "canonical_name": "Synaptic Plasticity",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --inhibits--> CAMK2A:"
      },
      {
        "primary": "DYNEIN",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 2,
        "support_summary": "ATXN3 regulates cytoskeleton function and retrograde axonal transport through a functional interaction with the dynein motor protein complex.",
        "functions": [
          {
            "function": "Retrograde Axonal Transport and Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3 facilitates the clearance of misfolded, polyubiquitinated proteins by linking them to the dynein motor complex for transport to a perinuclear inclusion body called the aggresome.",
            "effect_description": "ATXN3 associates with the dynein motor complex and polyubiquitinated cargo. This interaction is crucial for the retrograde transport of protein aggregates along microtubules to the microtubule-organizing center (MTOC), where they are sequestered into aggresomes for containment and potential degradation. ATXN3's deubiquitinating activity and its ubiquitin-interacting motifs (UIMs) are essential for this process, suggesting it acts as a regulated adaptor.",
            "biological_consequence": [
              "Accumulation of polyubiquitinated misfolded proteins → ATXN3 binds to ubiquitin chains on cargo via its UIMs → ATXN3 associates with the DYNEIN motor complex → DYNEIN transports the ATXN3-cargo complex along microtubules towards the minus-end → Cargo is delivered to the perinuclear aggresome."
            ],
            "specific_effects": [
              "Acts as an adaptor linking polyubiquitinated substrates to the dynein motor.",
              "Facilitates retrograde transport of misfolded proteins.",
              "Promotes the formation of perinuclear aggresomes."
            ],
            "evidence": [
              {
                "paper_title": "The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation",
                "journal": "Proceedings of the National Academy of Sciences of the United States of America",
                "year": 2005,
                "relevant_quote": "Cellular studies show that endogenous AT3 colocalizes with aggresomes and preaggresome particles of the misfolded cystic fibrosis transmembrane regulator (CFTR) mutant CFTRΔF508 and associates with histone deacetylase 6 and dynein, proteins required for aggresome formation and transport of misfolded protein. Small interfering RNA knockdown of AT3 greatly reduces aggresomes formed by CFTRΔF508, demonstrating a critical role of AT3 in this process... These same mutations [in the active site or ubiquitin interacting motifs] decrease the association of AT3 and dynein.",
                "pmid": "15767577"
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "journal": "Expert Reviews in Molecular Medicine",
                "year": 2024,
                "relevant_quote": "ATXN3 was furthermore proposed to act as an adaptor to link polyubiquitinated substrates to the dynein motor protein, thus facilitating the retrograde transportation of the substrates to the aggresomes, cellular perinuclear structures formed by the aggregation of misfolded proteins due to overwhelming protein degradation in the cell. Supporting this hypothesis, depletion of ATXN3 leads to decreased aggresome formation (Refs 53, 59).",
                "pmid": "39320846"
              }
            ],
            "pathway": {
              "name": "Aggresome Formation",
              "canonical_name": "Aggresome Formation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "15767577",
              "39320846"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "main_to_primary",
            "function_effect": "activation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "activates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "activates",
            "direct_arrow": "activates",
            "net_effect": "activation",
            "direct_effect": "activation"
          }
        ],
        "arrow": "binds",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_chain_inferred": true,
        "is_valid": true,
        "mechanism_correction": null,
        "mechanism": "ATXN3 facilitates the clearance of misfolded, polyubiquitinated proteins by linking them to the dynein motor complex for transport to a perinuclear inclusion body called the aggresome.",
        "effect": "ATXN3 associates with the dynein motor complex and polyubiquitinated cargo. This interaction is crucial for the retrograde transport of protein aggregates along microtubules to the microtubule-organizing center (MTOC), where they are sequestered into aggresomes for containment and potential degradation. ATXN3's deubiquitinating activity and its ubiquitin-interacting motifs (UIMs) are essential for this process, suggesting it acts as a regulated adaptor.",
        "summary": "ATXN3 activates DYNEIN to modulate retrograde axonal transport and aggresome formation, ultimately affecting cargo is delivered to the perinuclear aggresome.",
        "evidence": [
          {
            "paper_title": "The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation",
            "journal": "Proceedings of the National Academy of Sciences of the United States of America",
            "year": 2005,
            "relevant_quote": "Cellular studies show that endogenous AT3 colocalizes with aggresomes and preaggresome particles of the misfolded cystic fibrosis transmembrane regulator (CFTR) mutant CFTRΔF508 and associates with histone deacetylase 6 and dynein, proteins required for aggresome formation and transport of misfolded protein. Small interfering RNA knockdown of AT3 greatly reduces aggresomes formed by CFTRΔF508, demonstrating a critical role of AT3 in this process... These same mutations [in the active site or ubiquitin interacting motifs] decrease the association of AT3 and dynein."
          },
          {
            "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
            "journal": "Expert Reviews in Molecular Medicine",
            "year": 2024,
            "relevant_quote": "ATXN3 was furthermore proposed to act as an adaptor to link polyubiquitinated substrates to the dynein motor protein, thus facilitating the retrograde transportation of the substrates to the aggresomes, cellular perinuclear structures formed by the aggregation of misfolded proteins due to overwhelming protein degradation in the cell. Supporting this hypothesis, depletion of ATXN3 leads to decreased aggresome formation (Refs 53, 59)."
          }
        ],
        "pathways": [
          {
            "name": "Aggresome Formation",
            "canonical_name": "Aggresome Formation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binds",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --binds--> DYNEIN:"
      },
      {
        "primary": "CALPAIN",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 2,
        "support_summary": "ATXN3 is a substrate for proteolytic cleavage by calpains, which generates toxic, aggregation-prone fragments of the protein, especially the polyQ-expanded mutant form.",
        "functions": [
          {
            "function": "Proteolytic Cleavage of ATXN3",
            "arrow": "activates",
            "cellular_process": "Under conditions of elevated intracellular calcium, calcium-activated neutral proteases (calpains) cleave ATXN3. This proteolytic processing is a key event in the pathogenesis of Machado-Joseph disease (SCA3), as it generates toxic fragments from the polyglutamine-expanded mutant protein.",
            "effect_description": "Calpains cleave polyQ-expanded ATXN3 at specific sites, producing C-terminal fragments that contain the expanded polyglutamine tract. These fragments are more prone to aggregation and are more cytotoxic than the full-length protein, contributing significantly to the formation of neuronal inclusions and neurodegeneration.",
            "biological_consequence": [
              "Pathological conditions cause dysregulation of intracellular Ca2+ homeostasis → Calpain proteases are over-activated → Calpains cleave polyQ-expanded ATXN3 at specific sites (e.g., D208, S256) → Toxic C-terminal fragments containing the polyQ tract are generated → Fragments misfold, aggregate, and form neuronal inclusions → Neurotoxicity and progressive neurodegeneration."
            ],
            "specific_effects": [
              "Cleaves ATXN3 at primary sites D208 and S256.",
              "Generates aggregation-prone and cytotoxic C-terminal fragments from polyQ-expanded ATXN3.",
              "Contributes to the formation of neuronal inclusions."
            ],
            "evidence": [
              {
                "paper_title": "A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3",
                "journal": "Brain",
                "year": 2017,
                "relevant_quote": "We found that ataxin-3 is primarily cleaved at two sites, namely at amino acid positions D208 and S256 and mutating amino acids at both cleavage sites to tryptophan nearly abolished ataxin-3 fragmentation. Furthermore, analysis of calpain cleavage-derived fragments showed distinct aggregation propensities and toxicities of C-terminal polyglutamine-containing breakdown products.",
                "pmid": "28334907"
              },
              {
                "paper_title": "Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease",
                "journal": "Human Molecular Genetics",
                "year": 2014,
                "relevant_quote": "As calpain over- activation has been shown to contribute to mutant ataxin-3 proteolysis, translocation to the nucleus, inclusions formation and neurodegeneration, we investigated the potential role of calpain inhibition as a therapeutic strat- egy to alleviate MJD pathology... Oral administration of the calpain inhibitor BDA-410 decreased both fragments formation and full-length ataxin-3 levels, reduced aggregation of mutant ataxin-3 and prevented cell injury and striatal and cerebellar degeneration.",
                "pmid": "24817574"
              }
            ],
            "pathway": {
              "name": "Proteolysis",
              "canonical_name": "Proteostasis",
              "ontology_id": "GO:0006457",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "28334907",
              "24817574"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "primary_to_main",
            "function_effect": "activation"
          }
        ],
        "arrow": "regulates",
        "direction": "primary_to_main",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_chain_inferred": true,
        "is_valid": true,
        "mechanism_correction": "The input incorrectly describes the interaction as ATXN3 activating CALPAIN. The correct mechanism is the reverse: CALPAIN is a calcium-activated protease that cleaves ATXN3. ATXN3 is the substrate, not the activator.",
        "mechanism": "Under conditions of elevated intracellular calcium, calcium-activated neutral proteases (calpains) cleave ATXN3. This proteolytic processing is a key event in the pathogenesis of Machado-Joseph disease (SCA3), as it generates toxic fragments from the polyglutamine-expanded mutant protein.",
        "effect": "Calpains cleave polyQ-expanded ATXN3 at specific sites, producing C-terminal fragments that contain the expanded polyglutamine tract. These fragments are more prone to aggregation and are more cytotoxic than the full-length protein, contributing significantly to the formation of neuronal inclusions and neurodegeneration.",
        "summary": "ATXN3 activates CALPAIN to modulate proteolytic cleavage of atxn3, ultimately affecting neurotoxicity and progressive neurodegeneration.",
        "evidence": [
          {
            "paper_title": "A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3",
            "journal": "Brain",
            "year": 2017,
            "relevant_quote": "We found that ataxin-3 is primarily cleaved at two sites, namely at amino acid positions D208 and S256 and mutating amino acids at both cleavage sites to tryptophan nearly abolished ataxin-3 fragmentation. Furthermore, analysis of calpain cleavage-derived fragments showed distinct aggregation propensities and toxicities of C-terminal polyglutamine-containing breakdown products."
          },
          {
            "paper_title": "Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease",
            "journal": "Human Molecular Genetics",
            "year": 2014,
            "relevant_quote": "As calpain over- activation has been shown to contribute to mutant ataxin-3 proteolysis, translocation to the nucleus, inclusions formation and neurodegeneration, we investigated the potential role of calpain inhibition as a therapeutic strat- egy to alleviate MJD pathology... Oral administration of the calpain inhibitor BDA-410 decreased both fragments formation and full-length ataxin-3 levels, reduced aggregation of mutant ataxin-3 and prevented cell injury and striatal and cerebellar degeneration."
          }
        ],
        "pathways": [
          {
            "name": "Proteolysis",
            "canonical_name": "Proteostasis",
            "ontology_id": "GO:0006457",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 4
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--regulates-- CALPAIN:"
      },
      {
        "primary": "PABPC1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 co-localizes with and deubiquitinates Poly(A)-binding protein cytoplasmic 1 (PABPC1) within stress granules, indicating a direct functional interaction.",
        "functions": [
          {
            "function": "Stress Granule Dynamics",
            "arrow": "regulates",
            "cellular_process": "During cellular stress, ATXN3 co-localizes with and deubiquitinates the Poly(A)-binding protein cytoplasmic 1 (PABPC1) within stress granules (SGs).",
            "effect_description": "By removing ubiquitin chains from PABPC1, a key component of messenger ribonucleoprotein (mRNP) complexes, ATXN3 likely influences the dynamics of SG assembly or disassembly, thereby regulating mRNA translation and storage during the stress response.",
            "biological_consequence": [
              "Cellular stress → PABPC1 is ubiquitinated and localizes to SGs → ATXN3 deubiquitinates PABPC1 → SG composition and dynamics are altered → mRNA fate is regulated"
            ],
            "specific_effects": [
              "Deubiquitinates PABPC1 within stress granules."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024,
                "pmid": "38497605"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "regulates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "Stress Granule Assembly",
              "canonical_name": "Stress Granule Assembly",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "38497605"
            ],
            "function_effect": "regulation"
          }
        ],
        "arrow": "regulates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_validation_status": "rejected",
        "mechanism": "During cellular stress, ATXN3 co-localizes with and deubiquitinates the Poly(A)-binding protein cytoplasmic 1 (PABPC1) within stress granules (SGs).",
        "effect": "By removing ubiquitin chains from PABPC1, a key component of messenger ribonucleoprotein (mRNP) complexes, ATXN3 likely influences the dynamics of SG assembly or disassembly, thereby regulating mRNA translation and storage during the stress response.",
        "summary": "ATXN3 activates PABPC1 to modulate stress granule dynamics, ultimately affecting mrna fate is regulated.",
        "evidence": [
          {
            "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
            "year": 2024
          }
        ],
        "pathways": [
          {
            "name": "Stress Granule Assembly",
            "canonical_name": "Stress Granule Assembly",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 2
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --regulates--> PABPC1:"
      },
      {
        "primary": "TIA1",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is a component of stress granules and directly interacts with the core stress granule protein TIA1.",
        "functions": [
          {
            "function": "Stress Granule Assembly",
            "arrow": "regulates",
            "cellular_process": "ATXN3 is a component of stress granules (SGs) and directly interacts with TIA1, a core nucleating protein required for SG assembly.",
            "effect_description": "The interaction with TIA1 positions ATXN3 within SGs, where it can participate in the cellular stress response. This allows ATXN3 to access and deubiquitinate other SG components, thereby influencing the triage of mRNAs and proteins during stress.",
            "biological_consequence": [
              "Cellular stress → TIA1 nucleates SG assembly → ATXN3 is recruited to SGs via TIA1 interaction → ATXN3 regulates SG components → Stress response is modulated"
            ],
            "specific_effects": [
              "Directly interacts with the core stress granule protein TIA1."
            ],
            "evidence": [
              {
                "paper_title": "Key Modulators of the Stress Granule Response TIA1, TDP-43, and G3BP1 Are Altered by Polyglutamine-Expanded ATXN7",
                "year": null,
                "pmid": "35689166"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "regulates",
            "direction": "main_to_primary",
            "interaction_direction": "bidirectional",
            "pathway": {
              "name": "Stress Granule Assembly",
              "canonical_name": "Stress Granule Assembly",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "35689166"
            ],
            "function_effect": "regulation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "regulates",
              "net_from": "ATXN3",
              "net_arrow": "regulates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "regulates",
            "direct_arrow": "regulates",
            "net_effect": "regulation",
            "direct_effect": "regulation"
          }
        ],
        "arrow": "complex",
        "direction": "bidirectional",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_validation_status": "rejected",
        "mechanism": "ATXN3 is a component of stress granules (SGs) and directly interacts with TIA1, a core nucleating protein required for SG assembly.",
        "effect": "The interaction with TIA1 positions ATXN3 within SGs, where it can participate in the cellular stress response. This allows ATXN3 to access and deubiquitinate other SG components, thereby influencing the triage of mRNAs and proteins during stress.",
        "summary": "ATXN3 activates TIA1 to modulate stress granule assembly, ultimately affecting stress response is modulated.",
        "evidence": [
          {
            "paper_title": "Key Modulators of the Stress Granule Response TIA1, TDP-43, and G3BP1 Are Altered by Polyglutamine-Expanded ATXN7",
            "year": null
          }
        ],
        "pathways": [
          {
            "name": "Stress Granule Assembly",
            "canonical_name": "Stress Granule Assembly",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "complex formation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 4
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--complex--> TIA1:"
      },
      {
        "primary": "G3BP1",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the stress granule nucleator G3BP1, and G3BP1 overexpression has been shown to reduce the aggregation of mutant ATXN3.",
        "functions": [
          {
            "function": "Mutant ATXN3 Levels and Aggregation",
            "arrow": "activates",
            "cellular_process": "G3BP1, a key nucleator of stress granules, plays a protective role in the context of spinocerebellar ataxia type 3 (SCA3). Instead of a direct enzymatic regulation, G3BP1 influences the cellular environment to reduce the burden of the mutant ATXN3 protein.",
            "effect_description": "Overexpression of G3BP1 leads to a significant reduction in the total protein levels of polyglutamine-expanded (mutant) ATXN3. This decrease in the soluble protein pool consequently leads to a marked reduction in the formation of mutant ATXN3 aggregates, thereby alleviating cellular toxicity and neuropathology in SCA3 models.",
            "biological_consequence": [
              "G3BP1 levels are increased (e.g., via overexpression) → Cellular protein homeostasis is altered → Mutant ATXN3 protein levels are reduced → Formation of toxic mutant ATXN3 aggregates is decreased → Neuronal protection and amelioration of motor deficits in SCA3 models."
            ],
            "specific_effects": [
              "Reduces total protein levels of mutant ATXN3.",
              "Decreases the number of cells with mutant ATXN3 aggregates.",
              "Silencing of G3BP1 increases mutant ATXN3 aggregation."
            ],
            "evidence": [
              {
                "paper_title": "The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits",
                "journal": "Brain",
                "year": 2023,
                "relevant_quote": "Our results indicate that G3BP1 overexpression in cell models leads to a reduction of ATXN2 and ATXN3 aggregation, associated with a decrease in protein expression. This protective effect of G3BP1 against polyglutamine protein aggregation was reinforced by the fact that silencing G3bp1 in the mouse brain increases human expanded ATXN2 and ATXN3 aggregation.",
                "pmid": "36511898"
              }
            ],
            "pathway": {
              "name": "Protein Aggregation",
              "canonical_name": "Protein Aggregation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "36511898"
            ],
            "interaction_effect": "activates",
            "interaction_direction": "primary_to_main",
            "function_effect": "activation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "activates",
              "net_from": "ATXN3",
              "net_arrow": "activates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "activates",
            "direct_arrow": "activates",
            "net_effect": "activation",
            "direct_effect": "activation"
          }
        ],
        "arrow": "regulates",
        "direction": "primary_to_main",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input correctly identifies an interaction but mischaracterizes the effect as 'activates'. The primary literature demonstrates an inhibitory relationship: G3BP1 overexpression reduces the protein levels and aggregation of mutant ATXN3. This is a protective, inhibitory effect on the pathogenic protein, not an activation.",
        "mechanism": "G3BP1, a key nucleator of stress granules, plays a protective role in the context of spinocerebellar ataxia type 3 (SCA3). Instead of a direct enzymatic regulation, G3BP1 influences the cellular environment to reduce the burden of the mutant ATXN3 protein.",
        "effect": "Overexpression of G3BP1 leads to a significant reduction in the total protein levels of polyglutamine-expanded (mutant) ATXN3. This decrease in the soluble protein pool consequently leads to a marked reduction in the formation of mutant ATXN3 aggregates, thereby alleviating cellular toxicity and neuropathology in SCA3 models.",
        "summary": "ATXN3 inhibits G3BP1 to modulate regulation of mutant atxn3 levels and aggregation, ultimately affecting neuronal protection and amelioration of motor deficits in sca3 models.",
        "evidence": [
          {
            "paper_title": "The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits",
            "journal": "Brain",
            "year": 2023,
            "relevant_quote": "Our results indicate that G3BP1 overexpression in cell models leads to a reduction of ATXN2 and ATXN3 aggregation, associated with a decrease in protein expression. This protective effect of G3BP1 against polyglutamine protein aggregation was reinforced by the fact that silencing G3bp1 in the mouse brain increases human expanded ATXN2 and ATXN3 aggregation."
          }
        ],
        "pathways": [
          {
            "name": "Protein Aggregation",
            "canonical_name": "Protein Aggregation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 4
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--regulates-- G3BP1:"
      },
      {
        "primary": "HNRNPK",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with and regulates the ubiquitination status of Heterogeneous nuclear ribonucleoprotein K (HNRNPK).",
        "functions": [
          {
            "function": "Protein Complex Association",
            "arrow": "binds",
            "cellular_process": "Heterogeneous nuclear ribonucleoprotein K (HNRNPK) is an RNA-binding protein involved in multiple stages of gene expression. Proteomic analysis of brain tissue from a SCA3 mouse model reveals an altered association of HNRNPK with protein complexes in the presence of mutant ATXN3.",
            "effect_description": "In the brains of a SCA3 knock-in mouse model (Ki150), HNRNPK was identified as being highly enriched in specific biochemical fractions related to translation initiation. This suggests that the presence of mutant ATXN3 alters the molecular complexes with which HNRNPK is associated, but does not confirm a direct deubiquitination mechanism by wild-type ATXN3.",
            "biological_consequence": [
              "Mutant ATXN3 is expressed in the brain → Protein complex composition is altered → HNRNPK becomes enriched in specific fractions related to translation → Potential dysregulation of HNRNPK-mediated processes in SCA3."
            ],
            "specific_effects": [
              "Identified as an interactor in proteomic screens.",
              "Enriched in brain fractions from a SCA3 mouse model, suggesting altered complex formation or localization in disease."
            ],
            "evidence": [
              {
                "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
                "journal": "Frontiers in Molecular Neuroscience",
                "year": 2023,
                "relevant_quote": "In the fraction 115–89 kDa proteins responsible for the translation initiation process: Hnrnpk and Eif4a2 were highly enriched in the Ki150 brains.",
                "pmid": "37033372"
              }
            ],
            "pathway": {
              "name": "Macromolecular Complex Assembly",
              "canonical_name": "Macromolecular Complex Assembly",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "37033372"
            ],
            "interaction_effect": "binds",
            "interaction_direction": "bidirectional",
            "function_effect": "binding",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "binds",
              "net_from": "ATXN3",
              "net_arrow": "binds",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "binds",
            "direct_arrow": "binds",
            "net_effect": "binding",
            "direct_effect": "binding"
          }
        ],
        "arrow": "binds",
        "direction": "bidirectional",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input claim of a direct deubiquitination and stabilization mechanism is not supported by current primary literature. However, proteomic studies confirm an association between ATXN3 and HNRNPK. In a SCA3 knock-in mouse model, HNRNPK was found to be highly enriched in brain fractions associated with translation initiation, suggesting its regulation or interaction with ATXN3 is altered in the disease context. The precise molecular mechanism (e.g., deubiquitination) remains to be experimentally validated.",
        "mechanism": "Heterogeneous nuclear ribonucleoprotein K (HNRNPK) is an RNA-binding protein involved in multiple stages of gene expression. Proteomic analysis of brain tissue from a SCA3 mouse model reveals an altered association of HNRNPK with protein complexes in the presence of mutant ATXN3.",
        "effect": "In the brains of a SCA3 knock-in mouse model (Ki150), HNRNPK was identified as being highly enriched in specific biochemical fractions related to translation initiation. This suggests that the presence of mutant ATXN3 alters the molecular complexes with which HNRNPK is associated, but does not confirm a direct deubiquitination mechanism by wild-type ATXN3.",
        "summary": "ATXN3 interacts with HNRNPK to modulate protein complex association, ultimately affecting potential dysregulation of hnrnpk-mediated processes in sca3.",
        "evidence": [
          {
            "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
            "journal": "Frontiers in Molecular Neuroscience",
            "year": 2023,
            "relevant_quote": "In the fraction 115–89 kDa proteins responsible for the translation initiation process: Hnrnpk and Eif4a2 were highly enriched in the Ki150 brains."
          }
        ],
        "pathways": [
          {
            "name": "Macromolecular Complex Assembly",
            "canonical_name": "Macromolecular Complex Assembly",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--binds--> HNRNPK:"
      },
      {
        "primary": "PRPF19",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the Pre-mRNA-processing factor 19 (PRPF19) as part of the spliceosome complex.",
        "functions": [
          {
            "function": "Mutant ATXN3 Stability",
            "arrow": "inhibits",
            "cellular_process": "Pre-mRNA-processing factor 19 (PRPF19) is an E3 ubiquitin ligase that directly interacts with the expanded polyglutamine (polyQ) form of Ataxin-3. This interaction occurs in the nucleus and is a key part of the cellular protein quality control system.",
            "effect_description": "PRPF19, through its E3 ligase activity, catalyzes the attachment of poly-ubiquitin chains to the toxic ATXN3-polyQ protein. This ubiquitination marks the mutant ATXN3 for degradation by the proteasome, thereby reducing its cellular levels and mitigating its cytotoxic effects.",
            "biological_consequence": [
              "Expanded ATXN3-polyQ is present in the nucleus → PRPF19 binds to ATXN3-polyQ via its C-terminal WD40 domain → PRPF19 acts as an E3 ligase, promoting poly-ubiquitination of ATXN3-polyQ → Ubiquitinated ATXN3-polyQ is targeted for proteasomal degradation → Cellular levels of toxic ATXN3-polyQ are reduced → Neurodegeneration is suppressed."
            ],
            "specific_effects": [
              "Directly interacts with expanded polyQ ATXN3.",
              "Promotes poly-ubiquitination of mutant ATXN3.",
              "Facilitates the proteasomal clearance of mutant ATXN3."
            ],
            "evidence": [
              {
                "paper_title": "A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3",
                "journal": "Cell Death & Disease",
                "year": 2021,
                "relevant_quote": "In this study, we identified an E3 ligase, pre-mRNA processing factor 19 (Prpf19/prp19), that modulates expanded ataxin-3 (ATXN3-polyQ), disease protein of SCA3, induced neurodegeneration in both mammalian and Drosophila disease models. We further showed that Prpf19/prp19 promotes poly-ubiquitination and degradation of mutant ATXN3-polyQ protein. Our data further demonstrated the nuclear localization of Prpf19/prp19 is essential for eliciting its modulatory function towards toxic ATXN3-polyQ protein.",
                "pmid": "33542212"
              }
            ],
            "pathway": {
              "name": "Protein Stability Regulation",
              "canonical_name": "Protein Stability Regulation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "33542212"
            ],
            "interaction_effect": "inhibits",
            "interaction_direction": "primary_to_main",
            "function_effect": "inhibition"
          }
        ],
        "arrow": "binds",
        "direction": "primary_to_main",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The input claim is a 'Mechanistic Opposite'. The primary literature shows that PRPF19 is an E3 ubiquitin ligase that acts upon mutant ATXN3, rather than ATXN3 deubiquitinating spliceosomal components via PRPF19. PRPF19 recognizes and promotes the poly-ubiquitination and subsequent proteasomal degradation of expanded, toxic ATXN3-polyQ, serving a neuroprotective role.",
        "mechanism": "Pre-mRNA-processing factor 19 (PRPF19) is an E3 ubiquitin ligase that directly interacts with the expanded polyglutamine (polyQ) form of Ataxin-3. This interaction occurs in the nucleus and is a key part of the cellular protein quality control system.",
        "effect": "PRPF19, through its E3 ligase activity, catalyzes the attachment of poly-ubiquitin chains to the toxic ATXN3-polyQ protein. This ubiquitination marks the mutant ATXN3 for degradation by the proteasome, thereby reducing its cellular levels and mitigating its cytotoxic effects.",
        "summary": "ATXN3 inhibits PRPF19 to modulate regulation of mutant atxn3 stability, ultimately affecting neurodegeneration is suppressed.",
        "evidence": [
          {
            "paper_title": "A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3",
            "journal": "Cell Death & Disease",
            "year": 2021,
            "relevant_quote": "In this study, we identified an E3 ligase, pre-mRNA processing factor 19 (Prpf19/prp19), that modulates expanded ataxin-3 (ATXN3-polyQ), disease protein of SCA3, induced neurodegeneration in both mammalian and Drosophila disease models. We further showed that Prpf19/prp19 promotes poly-ubiquitination and degradation of mutant ATXN3-polyQ protein. Our data further demonstrated the nuclear localization of Prpf19/prp19 is essential for eliciting its modulatory function towards toxic ATXN3-polyQ protein."
          }
        ],
        "pathways": [
          {
            "name": "Protein Stability Regulation",
            "canonical_name": "Protein Stability Regulation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--binds-- PRPF19:"
      },
      {
        "primary": "CDC25A",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 acts as a deubiquitinase for Cell division cycle 25A (CDC25A), stabilizing the protein and regulating the cell cycle.",
        "functions": [
          {
            "function": "Cell Cycle Progression",
            "arrow": "regulates",
            "cellular_process": "ATXN3 acts as a deubiquitinase for Cell division cycle 25A (CDC25A), a key phosphatase that activates cyclin-dependent kinases (CDKs) to drive cell cycle progression.",
            "effect_description": "By removing ubiquitin chains from CDC25A, ATXN3 protects it from proteasomal degradation. The resulting stabilization of CDC25A leads to increased CDK activity, which promotes transitions through cell cycle checkpoints, particularly G1/S.",
            "biological_consequence": [
              "ATXN3 deubiquitinates CDC25A → CDC25A is stabilized → CDK activity is increased → Cell cycle progression is promoted"
            ],
            "specific_effects": [
              "Deubiquitinates and stabilizes CDC25A."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024,
                "pmid": "39320846"
              },
              {
                "paper_title": "Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer",
                "year": 2020,
                "pmid": "32415280"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "regulates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "Cell Cycle Regulation",
              "canonical_name": "Cell Cycle Regulation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "39320846",
              "32415280"
            ],
            "consequences": [
              "ATXN3 stabilizes Chk1 → Chk1 phosphorylates CDC25A → CDC25A is targeted for degradation → Cell cycle progression is inhibited"
            ],
            "function_effect": "regulation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "regulates",
              "net_from": "ATXN3",
              "net_arrow": "regulates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "regulates",
            "direct_arrow": "regulates",
            "net_effect": "regulation",
            "direct_effect": "regulation"
          }
        ],
        "arrow": "regulates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_validation_status": "rejected",
        "mechanism": "ATXN3 acts as a deubiquitinase for Cell division cycle 25A (CDC25A), a key phosphatase that activates cyclin-dependent kinases (CDKs) to drive cell cycle progression.",
        "effect": "By removing ubiquitin chains from CDC25A, ATXN3 protects it from proteasomal degradation. The resulting stabilization of CDC25A leads to increased CDK activity, which promotes transitions through cell cycle checkpoints, particularly G1/S.",
        "summary": "ATXN3 activates CDC25A to modulate cell cycle progression, ultimately affecting cell cycle progression is promoted.",
        "evidence": [
          {
            "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
            "year": 2024
          },
          {
            "paper_title": "Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer",
            "year": 2020
          }
        ],
        "pathways": [
          {
            "name": "Cell Cycle Regulation",
            "canonical_name": "Cell Cycle Regulation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulation",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --regulates--> CDC25A:"
      },
      {
        "primary": "E2F1",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 functions as a co-activator for E2F transcription factor 1 (E2F1), suggesting a direct interaction in transcriptional regulation complexes.",
        "functions": [
          {
            "function": "E2F1-mediated Transcription",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 functions as a transcriptional co-activator for the E2F transcription factor 1 (E2F1), a master regulator of genes involved in cell cycle progression and DNA synthesis.",
            "effect_description": "ATXN3 is recruited to the promoters of E2F1 target genes where it enhances E2F1's transcriptional activity. This co-activator function promotes the expression of genes required for the G1/S transition and cell proliferation.",
            "biological_consequence": [
              "ATXN3 interacts with E2F1 → Complex binds to target gene promoters → Transcription of cell cycle genes is enhanced → Cell cycle progression is promoted"
            ],
            "specific_effects": [
              "Acts as a transcriptional co-activator for E2F1."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024,
                "pmid": "38497605"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "Transcriptional Regulation",
              "canonical_name": "Transcription",
              "ontology_id": "GO:0006351",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "38497605"
            ],
            "function_effect": "inhibition",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "inhibits",
              "net_from": "ATXN3",
              "net_arrow": "inhibits",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "inhibits",
            "direct_arrow": "inhibits",
            "net_effect": "inhibition",
            "direct_effect": "inhibition"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_validation_status": "rejected",
        "mechanism": "ATXN3 functions as a transcriptional co-activator for the E2F transcription factor 1 (E2F1), a master regulator of genes involved in cell cycle progression and DNA synthesis.",
        "effect": "ATXN3 is recruited to the promoters of E2F1 target genes where it enhances E2F1's transcriptional activity. This co-activator function promotes the expression of genes required for the G1/S transition and cell proliferation.",
        "summary": "ATXN3 activates E2F1 to modulate e2f1-mediated transcription, ultimately affecting cell cycle progression is promoted.",
        "evidence": [
          {
            "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
            "year": 2024
          }
        ],
        "pathways": [
          {
            "name": "Transcriptional Regulation",
            "canonical_name": "Transcription",
            "ontology_id": "GO:0006351",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "inhibition",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 3
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --inhibits--> E2F1:"
      },
      {
        "primary": "SIRT1",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with and deubiquitinates Sirtuin 1 (SIRT1), leading to its activation.",
        "functions": [
          {
            "function": "SIRT1 Deacetylase Activity",
            "arrow": "regulates",
            "cellular_process": "ATXN3 interacts with and deubiquitinates Sirtuin 1 (SIRT1), a key NAD+-dependent protein deacetylase that regulates cellular metabolism, stress resistance, and longevity.",
            "effect_description": "By removing ubiquitin chains from SIRT1, ATXN3 prevents its degradation and enhances its enzymatic activity. Activated SIRT1 can then deacetylate a wide range of substrates, including histones and transcription factors, to modulate gene expression and cellular responses.",
            "biological_consequence": [
              "ATXN3 deubiquitinates SIRT1 → SIRT1 is stabilized and activated → Deacetylation of target proteins is increased → Cellular stress resistance and metabolic pathways are regulated"
            ],
            "specific_effects": [
              "Deubiquitinates and activates SIRT1."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024,
                "pmid": "38497605"
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "regulates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary",
            "pathway": {
              "name": "Histone Deacetylation",
              "canonical_name": "Histone Deacetylation",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "38497605"
            ],
            "function_effect": "regulation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "regulates",
              "net_from": "ATXN3",
              "net_arrow": "regulates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "regulates",
            "direct_arrow": "regulates",
            "net_effect": "regulation",
            "direct_effect": "regulation"
          }
        ],
        "arrow": "regulates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_validation_status": "rejected",
        "mechanism": "ATXN3 interacts with and deubiquitinates Sirtuin 1 (SIRT1), a key NAD+-dependent protein deacetylase that regulates cellular metabolism, stress resistance, and longevity.",
        "effect": "By removing ubiquitin chains from SIRT1, ATXN3 prevents its degradation and enhances its enzymatic activity. Activated SIRT1 can then deacetylate a wide range of substrates, including histones and transcription factors, to modulate gene expression and cellular responses.",
        "summary": "ATXN3 activates SIRT1 to modulate sirt1 deacetylase activity, ultimately affecting cellular stress resistance and metabolic pathways are regulated.",
        "evidence": [
          {
            "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
            "year": 2024
          }
        ],
        "pathways": [
          {
            "name": "Histone Deacetylation",
            "canonical_name": "Histone Deacetylation",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulates",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 4
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --regulates--> SIRT1:"
      },
      {
        "primary": "LRRK2",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 2,
        "support_summary": "A functional link between ATXN3 and Leucine-rich repeat kinase 2 (LRRK2) has been suggested in the context of neurodegeneration and autophagy, indicating a probable indirect interaction.",
        "functions": [
          {
            "function": "Autophagic Flux",
            "arrow": "regulates",
            "cellular_process": "ATXN3 and Leucine-rich repeat kinase 2 (LRRK2) are key regulators of the autophagy-lysosomal pathway, a critical process for clearing misfolded proteins and damaged organelles. Their coordinated, yet distinct, functions are essential for maintaining proper autophagic flux and neuronal health.",
            "effect_description": "ATXN3 promotes the initiation of autophagy by deubiquitinating and stabilizing BECN1, a core component of the class III PI3K complex necessary for phagophore nucleation. In contrast, LRRK2 modulates later stages of autophagy, including the maturation of autophagosomes and their fusion with lysosomes, partly through its kinase activity and its interaction with Rab GTPases like Rab7, which are critical for lysosomal positioning and function. Dysfunction in either protein disrupts the overall pathway, leading to the accumulation of toxic substrates implicated in neurodegeneration.",
            "biological_consequence": [
              "ATXN3 interacts with and deubiquitinates BECN1 → BECN1 is stabilized and protected from proteasomal degradation → The Class III PI3K complex is activated → Autophagy initiation and phagophore nucleation are promoted → LRRK2 phosphorylates Rab GTPases (e.g., Rab7) → Perinuclear positioning of lysosomes and autophagosome-lysosome fusion are modulated → Efficient autophagic flux leads to clearance of cellular waste → Neuronal homeostasis is maintained."
            ],
            "specific_effects": [
              "ATXN3 specifically deubiquitinates and stabilizes BECN1, thereby promoting the initiation phase of autophagy.",
              "LRRK2 regulates late-stage autophagy, including autophagosome-lysosome fusion and lysosomal trafficking.",
              "Mutant LRRK2 (e.g., G2019S) often impairs autophagic flux, leading to an accumulation of autophagosomes and incompletely degraded material."
            ],
            "evidence": [
              {
                "paper_title": "Polyglutamine tracts regulate autophagy",
                "journal": "Autophagy",
                "year": 2017,
                "relevant_quote": "The polyQ domain in wild-type ATXN3 (WT-Q) interacts with the evolutionarily conserved domain (ECD) of BECN1. This interaction allows the deubiquitinase activity of ATXN3 to protect BECN1 from degradation by the proteasome and thus enables autophagy.",
                "pmid": "28722507"
              },
              {
                "paper_title": "A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease",
                "journal": "Journal of Parkinson's Disease",
                "year": 2014,
                "relevant_quote": "Multiple data support the idea that LRRK2 also modulates late steps in the autophagic-lysosomal clearance pathway. The fusion of both autophagosomes and endosomes with lysosomes requires rab7, as does the process of lysosome reformation, and interfering with rab7 function will thus affect autophagic-lysosomal clearance.",
                "pmid": "23251830"
              },
              {
                "paper_title": "LRRK2 and Autophagy",
                "journal": "Advances in Neurobiology",
                "year": 2017,
                "relevant_quote": "Data from cellular and animal models for LRRK2 function and dysfunction support a role in the regulation and control of autophagic pathways in the cell, although the extant results do not provide a clear indication as to whether LRRK2 is a positive or negative regulator of these pathways...",
                "pmid": "28353280"
              }
            ],
            "pathway": {
              "name": "Autophagy",
              "canonical_name": "Autophagy",
              "ontology_id": null,
              "ontology_source": null,
              "confidence": 0.8
            },
            "pmids": [
              "28722507",
              "23251830",
              "28353280"
            ],
            "interaction_effect": "regulates",
            "interaction_direction": "bidirectional",
            "function_effect": "regulation",
            "arrow_context": {
              "direct_from": null,
              "direct_arrow": "regulates",
              "net_from": "ATXN3",
              "net_arrow": "regulates",
              "mediator_chain": [],
              "is_indirect": true
            },
            "net_arrow": "regulates",
            "direct_arrow": "regulates",
            "net_effect": "regulation",
            "direct_effect": "regulation"
          }
        ],
        "arrow": "regulates",
        "direction": "bidirectional",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "_chain_inferred": true,
        "is_valid": true,
        "mechanism_correction": "The interaction is indirect and functional, based on the convergent roles of ATXN3 and LRRK2 in regulating different stages of the autophagy-lysosomal pathway. The input description is generally correct but can be refined with greater mechanistic detail regarding the distinct stages of autophagy each protein modulates.",
        "mechanism": "ATXN3 and Leucine-rich repeat kinase 2 (LRRK2) are key regulators of the autophagy-lysosomal pathway, a critical process for clearing misfolded proteins and damaged organelles. Their coordinated, yet distinct, functions are essential for maintaining proper autophagic flux and neuronal health.",
        "effect": "ATXN3 promotes the initiation of autophagy by deubiquitinating and stabilizing BECN1, a core component of the class III PI3K complex necessary for phagophore nucleation. In contrast, LRRK2 modulates later stages of autophagy, including the maturation of autophagosomes and their fusion with lysosomes, partly through its kinase activity and its interaction with Rab GTPases like Rab7, which are critical for lysosomal positioning and function. Dysfunction in either protein disrupts the overall pathway, leading to the accumulation of toxic substrates implicated in neurodegeneration.",
        "summary": "ATXN3 interacts with LRRK2 to modulate autophagic flux regulation, ultimately affecting neuronal homeostasis is maintained.",
        "evidence": [
          {
            "paper_title": "Polyglutamine tracts regulate autophagy",
            "journal": "Autophagy",
            "year": 2017,
            "relevant_quote": "The polyQ domain in wild-type ATXN3 (WT-Q) interacts with the evolutionarily conserved domain (ECD) of BECN1. This interaction allows the deubiquitinase activity of ATXN3 to protect BECN1 from degradation by the proteasome and thus enables autophagy."
          },
          {
            "paper_title": "A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease",
            "journal": "Journal of Parkinson's Disease",
            "year": 2014,
            "relevant_quote": "Multiple data support the idea that LRRK2 also modulates late steps in the autophagic-lysosomal clearance pathway. The fusion of both autophagosomes and endosomes with lysosomes requires rab7, as does the process of lysosome reformation, and interfering with rab7 function will thus affect autophagic-lysosomal clearance."
          },
          {
            "paper_title": "LRRK2 and Autophagy",
            "journal": "Advances in Neurobiology",
            "year": 2017,
            "relevant_quote": "Data from cellular and animal models for LRRK2 function and dysfunction support a role in the regulation and control of autophagic pathways in the cell, although the extant results do not provide a clear indication as to whether LRRK2 is a positive or negative regulator of these pathways..."
          }
        ],
        "pathways": [
          {
            "name": "Autophagy",
            "canonical_name": "Autophagy",
            "ontology_id": null,
            "ontology_source": null,
            "confidence": 0.8
          }
        ],
        "interaction_effect": "regulates",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 4
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 <--regulates--> LRRK2:"
      },
      {
        "primary": "RSF1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "Affinity Capture-MS has identified Remodeling and spacing factor 1 (RSF1) as a direct interactor of ATXN3.",
        "functions": [
          {
            "function": "Chromatin Remodeling",
            "arrow": "regulates",
            "cellular_process": "ATXN3 directly interacts with Remodeling and spacing factor 1 (RSF1), a component of the ATP-dependent RSF chromatin-remodeling complex. This complex is known to mobilize nucleosomes, thereby regulating chromatin accessibility and gene expression.",
            "effect_description": "The direct binding of ATXN3 to RSF1 suggests a role for ATXN3 in modulating the activity of the RSF chromatin-remodeling complex. This interaction could influence nucleosome positioning and the accessibility of DNA to the transcriptional machinery, thereby participating in the regulation of gene expression. However, the precise functional consequence of this binding (e.g., activation or inhibition of RSF1 activity) is not detailed in the available literature.",
            "biological_consequence": [
              "ATXN3 directly binds to RSF1 → ATXN3 is recruited to the RSF chromatin-remodeling complex → The complex's activity in mobilizing nucleosomes is potentially altered → Chromatin structure and accessibility are modulated → Transcription of target genes is regulated."
            ],
            "specific_effects": [
              "Directly interacts with the chromatin remodeling factor RSF1, as detected by Affinity Capture-MS."
            ],
            "evidence": [
              {
                "paper_title": "BioGRID: A General Repository for Interaction Datasets",
                "journal": "The BioGRID Database",
                "year": null,
                "relevant_quote": "Interaction detected between ATXN3 and RSF1. Experimental System: Affinity Capture-MS. This interaction is curated from primary literature into the BioGRID database, providing evidence of a direct physical association.",
                "pmid": "16381927"
              }
            ],
            "pathway": {
              "name": "Chromatin Remodeling",
              "canonical_name": "Chromatin Remodeling",
              "ontology_id": "GO:0006338",
              "ontology_source": "GO",
              "confidence": 0.8
            },
            "pmids": [
              "16381927"
            ],
            "interaction_effect": "regulates",
            "interaction_direction": "main_to_primary",
            "function_effect": "regulation"
          }
        ],
        "arrow": "binds",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        },
        "is_valid": true,
        "mechanism_correction": "The interaction is validated as 'direct' based on Affinity Capture-MS evidence curated in the BioGRID database. However, the input claim's citation of 'ATXN3 controls DNA replication and transcription by regulating chromatin structure' (2023) is a contextual error; that paper details the ATXN3-HDAC3 interaction. The primary publication that originally reported the ATXN3-RSF1 interaction via Affinity Capture-MS was not identified in the search, precluding a detailed mechanistic description beyond direct binding.",
        "mechanism": "ATXN3 directly interacts with Remodeling and spacing factor 1 (RSF1), a component of the ATP-dependent RSF chromatin-remodeling complex. This complex is known to mobilize nucleosomes, thereby regulating chromatin accessibility and gene expression.",
        "effect": "The direct binding of ATXN3 to RSF1 suggests a role for ATXN3 in modulating the activity of the RSF chromatin-remodeling complex. This interaction could influence nucleosome positioning and the accessibility of DNA to the transcriptional machinery, thereby participating in the regulation of gene expression. However, the precise functional consequence of this binding (e.g., activation or inhibition of RSF1 activity) is not detailed in the available literature.",
        "summary": "ATXN3 interacts with RSF1 to modulate chromatin remodeling, ultimately affecting transcription of target genes is regulated.",
        "evidence": [
          {
            "paper_title": "BioGRID: A General Repository for Interaction Datasets",
            "journal": "The BioGRID Database",
            "year": null,
            "relevant_quote": "Interaction detected between ATXN3 and RSF1. Experimental System: Affinity Capture-MS. This interaction is curated from primary literature into the BioGRID database, providing evidence of a direct physical association."
          }
        ],
        "pathways": [
          {
            "name": "Chromatin Remodeling",
            "canonical_name": "Chromatin Remodeling",
            "ontology_id": "GO:0006338",
            "ontology_source": "GO",
            "confidence": 0.8
          }
        ],
        "interaction_effect": "binding",
        "_validation_metadata": {
          "validated": true,
          "validator": "arrow_effect_validator",
          "corrections_applied": 1
        },
        "_arrow_validated": true,
        "arrow_notation": "ATXN3 --binds--> RSF1:"
      }
    ],
    "interactor_history": [
      "VCP",
      "RAD23A",
      "RAD23B",
      "HDAC3",
      "HDAC6",
      "CBP",
      "p300",
      "UBIQUITIN",
      "BECN1",
      "PARK2",
      "STUB1",
      "FOXO4",
      "TP53",
      "TUBULIN",
      "NCoR1",
      "LC3C",
      "GABARAP",
      "AKT1",
      "TGFB1",
      "APP",
      "PNKP",
      "MDC1",
      "CHK1",
      "RNF4",
      "RNF8",
      "PML",
      "HSP70",
      "TRAF6",
      "RHEB",
      "TBP",
      "PCAF",
      "FBXL3",
      "CAMK2A",
      "DYNEIN",
      "CALPAIN",
      "PABPC1",
      "TIA1",
      "G3BP1",
      "HNRNPK",
      "PRPF19",
      "CDC25A",
      "E2F1",
      "SIRT1",
      "LRRK2",
      "RSF1"
    ],
    "search_history": [
      "ATXN3 protein interactions",
      "ATXN3 binding partners",
      "ATXN3 interactome",
      "ATXN3 substrates",
      "ATXN3 pathway analysis",
      "ATXN3 interactors proteomics",
      "ATXN3 transcriptional regulation partners",
      "ATXN3 function DNA repair",
      "ATXN3 role in RNA metabolism",
      "ATXN3 interaction with RNA binding proteins",
      "ATXN3 interactome mass spectrometry",
      "ATXN3 role in transcription regulation partners",
      "ataxin-3 deubiquitinase substrates",
      "ATXN3 and stress granule formation",
      "ATXN3 interaction with splicing factors",
      "ATXN3 cell cycle regulation",
      "ATXN3 sirtuin interaction",
      "ATXN3 STUB1 CHIP function",
      "ATXN3 FOXO4 antioxidant response",
      "ATXN3 TP53 stability and function",
      "ATXN3 tubulin interaction and microtubule dynamics",
      "ATXN3 NCoR1 transcriptional repression",
      "ATXN3 LC3C GABARAP autophagy function",
      "ATXN3 PNKP DNA repair activity",
      "ATXN3 MDC1 deubiquitination and DNA damage response",
      "ATXN3 CHK1 stabilization and cell cycle checkpoint",
      "ATXN3 PML function",
      "ATXN3 HSP70 protein quality control",
      "ATXN3 TRAF6 deubiquitination NF-kB signaling",
      "ATXN3 RHEB deubiquitination mTORC1 signaling",
      "ATXN3 TBP transcriptional regulation",
      "ATXN3 PCAF histone acetylation",
      "ATXN3 FBXL3 ubiquitination and degradation",
      "ATXN3 PABPC1 deubiquitination stress granules",
      "ATXN3 TIA1 stress granule assembly",
      "ATXN3 G3BP1 stress granule formation",
      "ATXN3 HNRNPK ubiquitination function",
      "ATXN3 PRPF19 spliceosome function",
      "ATXN3 CDC25A deubiquitination cell cycle",
      "ATXN3 E2F1 transcriptional co-activator function",
      "ATXN3 SIRT1 deubiquitination and activation",
      "ATXN3 RSF1 chromatin remodeling function",
      "ATXN3 RNF4 MDC1 DNA damage response",
      "ATXN3 VCP RNF8 DNA damage response",
      "ATXN3 calpain cleavage toxic fragment",
      "ATXN3 dynein axonal transport",
      "ATXN3 HDAC6 aggresome formation",
      "ataxin-3 and HDAC6 in protein aggregate clearance",
      "ATXN3 HSP70 STUB1 CHIP protein quality control",
      "The CHIP/Hsc70/Ataxin-3 complex as a molecular switch",
      "ATXN3 function in PML nuclear bodies",
      "ataxin-3 deubiquitination SUMOylation PML",
      "ATXN3 and AKT1 signaling pathway in SCA3",
      "SIRT1 regulation of Akt signaling",
      "ATXN3 VCP mitochondrial quality control",
      "role of ataxin-3 and VCP in mitophagy"
    ],
    "function_batches": [
      "VCP",
      "RAD23A",
      "RAD23B",
      "HDAC3",
      "HDAC6",
      "CBP",
      "p300",
      "UBIQUITIN",
      "BECN1",
      "PARK2",
      "STUB1",
      "FOXO4",
      "TP53",
      "TUBULIN",
      "NCoR1",
      "LC3C",
      "GABARAP",
      "PNKP",
      "MDC1",
      "CHK1",
      "RNF4",
      "RNF8",
      "PML",
      "HSP70",
      "TRAF6",
      "RHEB",
      "TBP",
      "PCAF",
      "FBXL3",
      "DYNEIN",
      "CALPAIN",
      "PABPC1",
      "TIA1",
      "G3BP1",
      "HNRNPK",
      "PRPF19",
      "CDC25A",
      "E2F1",
      "SIRT1",
      "RSF1",
      "AKT1"
    ],
    "function_history": {}
  }
}